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Chronic rhinosinusitis is a common condition that is responsible for considerable
morbidity and utilisation of health care resources. Surgery remains the mainstay of
treatment of sinus disease that does not respond to medical management. Despite
recent advances in Endoscopic Sinus Surgery(ESS), the most common complications
of surgery are adhesion formation and scarring, which result in recurrence of disease
and poor patient outcomes. Hyaluronic acid based nasal packing and Insulin-like
growth factor 1 (IGF-l), are recent therapeutic interventions that have shown promise
in enhancing the healing process after surgery. They have not however been trailed in
a model of chronic rhinosinusitis. The aim of this study was to validate an animal
model of chronic sinusitis and then assess their efficacy in enhancing mucosal healing
after ESS, in such a model.
Methods and Materials
Under endoscopic guidance, mucosal injuries were created in 18 sheep that were
infested with the nasal parasite oestrous ovus. This infestation induces an eosinophilic
chronic rhinosinusitis. In 9 sheep, one side of the nasal cavity was packing with
Merogel, a hyaluronic acid based pack, and in the other 9, Merogel impregnated with
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IGF-I was used. The opposite side of the nasal cavity was left unpacked as a control.
Serial biopsies were taken at days 28,56,84 and ll2-post injury and assessed via light
and electron microscopic techniques for mucosal reepithelialisation, epithelial height,
ciliary beat frequency and the macroscopic presence of intranasal adhesions'
Results
In comparison to healthy sheep, the presence of the oestrous ovus parasite and the
ensuing eosinophil driven inflammation resulted in significantly impaired mucosal
healing. The use of Merogel packing had no significant effect on mucosal healing.
The use of Merogel/IcF-1 packing had a significant deleterious effect on epithelial
reciliation. Neither packing had any effect on adhesion formation.
Conclusions
The sheep model has been validated as a suitable one for chronic rhinosinusitis' The
use of Merogel packing has no significant effect on mucosal healing after ESS. The
use of Merogel/IGF-1 packing has a deleterious effect on mucosal reciliation after
ESS. The sheep model will prove useful to study the effect of various interventions
to improve healing after ESS.
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Aims
The aims of this study were as follows.
1) To develop and validate a sheep model of chronic sinusitis which is suitable
for the study of endoscopic sinus surgery techniques and therapeutic
interventions to enhance post-operative healing.
2) To determine whether a hyalwonic acid-based nasal packing, Merogel@,
would confer any beneficial effect on nasal mucosal healing after endoscopic
sinus surgery
3) To determine whether a hyaluronic acid-based nasal packing, Merogel@,
impregnated with InsulinJike growth factor 1, would confer any beneficial




Chronic rhinosinusitis is one the most coÍrmon disease processes seen by medical
practitioners and represents a significant social and economic burden on our society.
In the USA and Australia, it affects about 18% of the population at some time or
¿1e1þs¡[1ì. In the USA, it is believed to affect approximately 30 million patients and
thus accounts for about 2Yo of all visits to physicians.[2]. It has been reported as the
most commonly reported chronic disease process in health surveys, with at least l5o/o
of the respondents having reported an episode of sinusitis lasting at least 3 months. It
is the 5th leading reason for antibiotic prescription, and the total yearly cost in the
USA was estimated at2.4 billion dollars, not including the costs of surgery or of
investigative imaging [3]. The initial management of theses patients involves the use
of medical therapy such as nasal steroid sprays, oral antibiotics, nasal saline
douching, nasal decongestants and analgesicsla]. However, it is estimated that up to
80% of these patients develop chronic rhinosinusitis which may requires surgical
intervention[1]. Endoscopic sinus surgery (ESS) is the most conìmon Ear Nose and




In order to understand the pathophysiology of chronic sinusitis, the concepts that
underlie ESS, and the rationale behind the attempts to enhance mucosal healing, it is
important to briefly consider some fundamental aspects of paranasal sinus anatomy
and physiology. The human paranasal sinuses consist of a number of hollow, bony
walled "cells" which drain via their ostia to each other and ultimately to the nasal
cavity via a complex series of drainage pathways. These cells lie adjacent to the
orbits laterally, the skull base and olfactory fossa superiorly, the nasal cavity medially
and the oral cavity inferiorly. The mucosal lining of the nasal cavity and paranasal
sinuses is pseudo-stratif,red, columnar epithelium which is ciliated There are, on
aveÍage,5 ciliated cells present for every one mucous cell, and each ciliated cell has
about 200 cilia. The goblet cells are responsible for the secretion of nasal mucous.
The epithelium, as well as being the integral part of the mucociliary clearance system
which will be discussed below, also acts as a physical barrier to exogenous agents. [3,
8, el
The Nasal Mucociliary System
The nasal mucociliary system plays a central role in the primary defence of the
respiratory tract from inhaled material. The function of mucociliary clearance was
initially described in the 1830rlto' 111. Since then, much has been done to describe the
function of this system and its associated components
Cilia are actively motile, microscopic projections from epithelial cell surface
surfaces. They are composed of 9 sets of paired microtubules, laying in a vertical
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plane, which lie peripherally surrounding2 central microtubules, the 9f2
configuration. These paired microtubules are linked to each other by filaments of a
substance called nexin, and are also linked radially by dynein arms with ATPase
activity. These also have dilated heads that can link with structures on the central
microtubules. Ciliary movement occurs in two phases, the effective þower) strike,
and the recovery (preparatory) stroke. Movement occurs due to movement of the 9
paired microtubules against each other, powered by interactions between ATP and the
ATPase in the dynein arms, resulting in movement of the erect cilia in an arc which is
vertical relative to the cell surface during the active phase, and then a sideways
movement of bent cilia near the surface of the cell during the recovery phase. The
movement of many cilia in a coordinated fashion is described as metachronous
movement[1-16].
Integral to mucociliary function is mucous. It is composed of glycoproteins, water
and ions, and is secreted by serous glands, mucous glands, goblet cells and also
produced by transudation from blood vesselsll1]. The nasal mucous exists in a double
layer. This consists of a sol, or aqueous layer, which lies closest to the epithelial
surface, and a gel layer lying superficially. During the active phase, the tips of the
cilia project into the gel layer, but move only in the sol layer during the recovery
phase. In this way, the active phase produces movement of the gel layer.ll1,16,l7l.
Further discussion of the intricacies of the nasal mucous, and its interaction with the
cilia lies beyond the scope of this work.
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In the uppff respiratory tract, cilia are universally found on the epithelium except for
the nasal vestibule, the squamous lined areas of the larynx, pharlmx and nasopharynx
and the olfactory epithelium. ln the lower respiratory tract, ciliated epithelium
extends to the respiratory bronchioles to the level of the non-alveolat *u¡.[15J. The
function of the mucociliary system is the removal of trapped inhaled particles from
the respiratory tract. Particles larger than 12.5 microns in size become trapped in the
mucous, and are eventually transported towards the nasopharynx where they can then
be expelled or digested.[11, 1s].
The natural drainage pathways of paranasal sinuses
The concept of the mucociliary drainage pathways is central in the trnderstanding of
chronic rhinosinusitis and ESS. In a series of classic studies in canine models,
Hilding demonstrated the course of the natural mucociliary pathways in the paranasal
sinus complex and showed that the majority of mucociliary clearance was directed
posteriorly towards the nasopharynx[l8J. He also characterised the drainage of the
frontal sinus complex in a canine t¡s¿s1[191. In human subjects, King examined
mucociliary clearance pathways and demonstrated that clearance continued to occur
via the natural ostia of the sinuses, even when an inferior meatal antrostomy had been
performed[20]. Friedmann further confirmed this preferential drainage through the
natural ostia using a canine model, and nuclear medicine scanning to track
mucociliary clearance, which demonstrated drainage via the natural pathways and the
middle meatus, even when drainage was gravitationally more advantageous via the
surgically created inferior meatal antrostomyl21]. Messerklinger showed that in the
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human maxillary sinus, the natural pathway of mucociliary flow originates in the
floor of the sinus, flows in a star shape and then ascends in a spiral fashion towards
the middle meatus (the natural ostium of the maxillary sinus)[22J. In the human
frontal sinus, there is a lateral pathway from the lateral aspect of the floor of the sinus
to the frontal ostium and then down on the lateralwall of the frontal recess, and a
medial pathway which ascends from the frontal sinus ostium along the medial wall of
the frontal sinus to the level of the intersinus septum[231. A thorough understanding of
these natural pathways of mucociliary drainage, and the observation that this system
would work in preference to artihcially created pathways form the basis of the
theories underlying functional endoscopic sinus surgery (FESS)
Pathogenesis of sinusitis - disruption of mucociliary clearance
The basic underlying process in the pathogenesis of chronic rhinosinusitis is
disruption to the natural function of mucociliary clearance from the paranasal sinus
complex. Stammberger, in one of his landmark papers on the anatomic and
physiological considerations relevant to ESS, described an ongoing cycle where
disorders in mucociliary cIearcnce, and changes in the mucosa and mucous
composition result in blockage of the natural ostia and drainage pathways, which in
turn leads to further metaplasia of the mucosa, further loss of cilia and then further
derangement of the mucociliary system. The result of this is mechanical blockage of
the middle meatus which then allows for the sinus to become permanently infected,
and allows spread of this infection throughout the paranasal sinus complex[24).
Numerous studies have been performed which support this theory. As far back as the
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1930s, Hilding demonstrated that interference with natural mucociliary clearance
resulted in chronic rhinosinusitis in a canine modelllg' 25]. Since then, much work has
been performed to highlight the importance of a normally functioning mucociliary
clearance system to the health of the paranasal sinuses. In a rabbit model, Czaja et al.
showed that obstruction of the mucociliary drainage pathways of an infected
maxillary sinus resulted in chronic infection in that sinus, with the resultant
histopathological changes in the ciliated epithelium described previously, with then
further deleterious effects on mucociliary clearance. These changes did not occur in
experimental subjects whose sinuses were inoculated with bacteria but whose natural
drainage pathways were left unobstructed, nor in subjects whose sinuses were
obstructed but not infected, suggesting the important role both factors play in the
development of chronic rhinosinusilisl26J. A number of other authors have also
induced chronic rhinosinusitis in murine models by occluding the natural mucociliary
drainage pathways of the paranasal sinuses with exogenous materials.
Histopathological analysis of mucosal samples showed similar changes to those
described previously 127,281.In a study on patients who had undergone ESS,
Waguespack performed endoscopic assessment of mucociliary transport pathways
using powdered graphite as a visible tracer. Mucociliary stasis in the ethmoid cavity
was the most common finding associated with recurring sinusitis after ESS l29l.In a
series of 100 patients, Schaefer et al commented that the formation of post operative
adhesions which lead to obstruction of the mucociliary drainage pathways of the
ethmoid and maxillary sinuses lead to sinu5l1i5[30].
Page20
Further evidence of the importance of the mucociliary clearance system is evidenced
by studies performed in patients with congenital derangements in ciliary structure and
ftrnction. There are a number of conditions collectively know as primary ciliary
dyskinesia, who have ultra structural abnormalities in their cilia resulting in decreased
ciliary action or in the case of Kartagener's syndrome, immotile cilia. Patients with
these conditions have poor clearance of mucous and debris from their lungs and
resultant chronic chest disease[31-33] t341. V/ith regards to sinus disease, other work
has noted increased sinus infecti6ns[34-39J, and documented alterations in mucociliary
fuction[¡S,40,411.
Animal Models of Chronic sinusitis - histopathological changes
When the histopathological changes that accompany chronic sinusitis are studied, one
can understand the mechanisms of disruption to mucociliary clearance. Analysis and
documentation of these changes also allows the assessment and validation of newer
models of sinusitis that are more relevant modern ESS techniques. Numerous studies
have been performed in animal models, which document the effect of chronic
rhinosinusitis on the mucosal lining of the paranasal sinuses and the mucociliary
transport system. In a rabbit model of bacterial sinusitis, after an initial increase in
CBF, there v¡as an almost complete loss (86%) of viable ciliated epithelium v/as seen
after 5 days of infection, and the authors also suggested that this was due to ischaenúc
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and other changes secondary to the infection rather that due to bacterial 1s)dn5[42J
Again in a rabbit model of chronic sinusitis, Czaja et al showed a significant increase
in ciliary ultra-structural abnormalities as demonstrated by electron microscopy, and
that once over 10% of the cilia were abnormal, there was a significant effect on
ciliary beat frequencyla3J. This model also demonstrated that chronic sinusitis
resulted in loss of ciliated epithelium, cell necrosis, basement membrane thickening,
and disorganised patterns of mucociliary clearance and resulting pooling and
stagnation of mucous t261. In further rabbit models, Benninger et al demonstrated that
the presence of chronic sinusitis resulted in a loss of epithelium[44], Marks showed
epithelial necrosis, loss of cilia and sloughing associated with an intense
polymorphonuclear infiltration[27], as did Schlosser et a1[45].
Human studies on Chronic Sinusitis - histopathological changes
In addition to the work performed in animal models, the numerous studies have been
conducted in human subjects to demonstrate the detrimental effect of rhinosinusitis
on both cilia and mucociliary clearance in humans. In a series of over 2500 patients
undergoing ESS for chronic sinusitis, mucosal samples showed features such as
increases in glandular structure, thicker mucous, thickened basement membranes,
squamous metaplasia, an increase in ultra structural ciliary abnormalities and an
overall decrease in cilia[46]. In studies on nasal brushings from patients with
rhinosinusitis, Maurizi et al. demonstrated numerous non specific ciliary
abnormalities as assessed by electron microscopy, and also, slower mucociliary
transport times measured by the saccharin test technique þTl.lnfurther work on
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patients with chronic sinusitis, slower mucociliary transport was noted compared to
controls, but there was no difference in ciliary beat frequency between the controls
subjects and those with sinusitis. These findings suggested that the sinus infection
may have affected the nasal mucous, resulting in overall decreased transport
times[48]. In another study on human patients, no signihcant differences in ciliary
beat frequency were seen between control subjects and patients with chronic sinusitis
[49]. Toskala also demonstrated a significant loss of ciliated cells and replacement
with non-ciliated columnar epithelium, and an increase in compound and shortened
cilia, in patients with chronic rhinosinusitislsO]. Similar ultra structural ciliary
abnormalities were seen in electron microscopy studies on samples from patients with
chronic sinusitis and recurrent infections in a study by Fontoillet et al [51], and also by
Carsons et al who specifically noted the presence of focal areas of micro tubular
adhesions as well as a generalised loss of ciliated epithelium in mucosal samples
from children with viral upper respiratory tract infectionsls2]. Mygind et al.
demonstrated ciliary ultra structural abnormalities as well as delays in mucociliary
transport time in patients with viral upper respiratory tract infectiensl37l, ¿¡¡fl
Albegger et al. described abnormal "hair like" hlaments in the ciliated epithelium
patients with chronic rhinosinusitis.[53].
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Principles of Endoscopic Sinus Surgery
As stated previously, the mainstay of treatment of chronic sinusitis is medical
management. However, for those patients whose symptoms are refractory to medical
treatment, ESS becomes the next treatment option. ESS was initially practiced in the
mid 1980s based on the theories of Messerklinger. His theories were based on the
animal and human studies previously discussed, which described the complex system
of pathways by which the paranasal sinuses drained in to the nasal cavity, and the
importance of these pathways in maintaining the health of the sinuses. He described
the relationship between obstruction of these pathways, mucous retention, inadequate
ventilation and then subsequent infection. Very importantly, he realised the
importance of the observations that mucociliary clearance was directed towards the
natural sinus ostium, even in the presence of artificially created ostia. His technique
was then focussed on the removal of diseased tissue, restoration of the natural
drainage pathways and preservation of as much of the healthy sinus mucosa and
architecture. Due this aim of preserving the physiological functioning of the sinuses,
Kennedy coined the term Functional Endoscopic sinus surgery (FESS)[6]. This
technique was also facilitated by the development and advancements in endoscopic
technology, which afforded improved access with minimal morbidity and a magnified
view of the paranasal sinuses, surgical instruments, both non powered and powered
which allowed manipulation of the sinus tissues, and finally, advanced radiology
techniques such as computerised tomography which afforded the surgeons improved
diagnostic abilities and also and anatomic road map for their surgery.l6,l,24,30,54l.
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ESS was then pioneered and popularised in the USA by Kennedyl7] and in Europe by
Stammbergerl24l.
Efficacy Of ESS
However, at present there is a paucity of good long-term outcome studies which help
predict which groups of patients may most beneht ¡ott1g55t3J.
Kennedy reported the results of 120 patients who had undergone ESS and were
followed up for an average of 18 months post operatively. Of these patíents,TIYo
were having revision surgery, so they were classified as having disease that was
resistant to both medical and surgical treatment. A major improvement in symptoms
was noted by 85% of patients, while a mild improvement was noted in a further
12.5%. When these subjective results were compared'ù/ith objective endoscopic
assessment of the healed sinuses, it was noted that only 45o/o of the patients had
normal, disease free sinuses on examination. The Kennedy system of grading sinus
disease, as assessed by computerised tomograph, was a reliable predictor of a
continuing disease process when assessed objectively by the surgeon, but did not
correlate with subjective improvements reported by the patient[55]. Schaefer et al
reported on a series of 200 consecutive patients undergoing ESS who were followed
up for an average of 5 month. Of these, 83% reported their syrnptoms improved
significantly and were also noted to have a patent ostiomeatal complex on endoscopy,
while a further 10 o/o were improved but did have 1 episode of sinusitis during the
follow up period. Of this group, 80% had a normal healthy ostiomeatal complex at
postoperative nasoendoscopy.[301. TotI'el reported that in a series of 785 patients
Page25
followed up at 72 months post ESS, 90.75% had complete resolution of the symptom
of nasal obstruction, S3.3yo reported complete resolution of post nasal drip, and
84.4% had a complete resolution of midfacial pain. Of the remaining patients, almost
all reported some improvement, with less thanl/o of patients reporting that any of
these 3 symptoms had not changed after ESS. At the 3 year follow up mark, the
number of patients reporting complete resolution of these three symptoms had
reduced to 88.3%, 81.5% and 80% respectively, but the number reporting no change
was still less than lo/o in each synrptom category[56J. Levine presented a series of 250
patients, all of whom had failed medical management, and 13 of whom had previous
surgery. Of the patients with nasal polyposis, 89.7% were judged by both the surgeon
and the patient as having been successfully treated, after a follow up period of 18
months. Of those with chronic sinusitis, the success rate was 80.2yr1571. In a series of
145 patients followed up for 24 months, 91.8% of patients who responded to a
postoperative questionnaire (61 patients) indicated that their s¡rmptoms were
improved or indeed, completely resolved. At this same time period, 94.08% of the
middle meatuses were still patent[58]. Using the Chronic Sinusitis Survey (CSS), and
the SF-36 Health survey, both previously validated health assessment questionnaires,
Metson and Glicklich assessed the change in symptomatology in 108 patient with
chronic rhinosinusitis who were treated with ESS. With regards to the CSS scores,
82o/o of patients had a clinically and statistically significant improvement in their
synptoms after ESS. Using the SF-36, which is a better indicator of overall quality of
life and global function, 75o/o of the general health categories showed a significant
improvement 12 months after ESSt59l. In the field of frontal sinus surgery, which has
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historically been a clinically difficult problem, the same authors reported a37Yo
improvement in symptom scores 12 months after ESS, and also noted significant
reduction in medication use after surgery. They noted that these results were not as
promising as those seen when ESS was performed for non-frontal disease, but was
nevertheless clinically significant[60ì.
One of the few studies to examine long term outcomes of ESS reported on a series of
72 patientswith an average follow-up period of 7.8 years. These were in fact from the
same cohort of patients that Kennedy reported ottin1992 [55]. Ninety eight point four
percent of these patients reported via a questionnaire that they still had an
improvement in their symptoms in comparison to prior to surgery. In this long term
follow up, it was noted that the presence of ongoing disease in the sinuses, as
assessed by endoscopy at 18 months post operatively, correlated with the need for
revision surgery, while symptom scores al"thattime did not. These results emphasis
the importance of complete healing of the mucosa, even in the absence of clinical
syrnptoms, and add weight to the usefulness of attempts to improve the healing
process ¿¡¡e1 P55[6]' 62].
Benefits of Sinus Surgery - Histopathological Studies
As well as the subjective improvements in symptomatology reported by patients, it is
also important to document objective changes in the health of the sinuses in order to
demonstrate the efficacy of treatments. There have been numerous animal studies to
demonstrate the benetit of sinus sugery in the treatment of sinusitis. ln a rabbit
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model of chronic sinusitis, Czaja and McCaffrey demonstrated that performing
middle meatal antrostomies could reverse the ciliary and other epithelial
histopathological abnormalities, and return the ciliary beat frequency (CBF) to a
normal rate. Six weeks after surgery \¡/as performed, the rabbits with chronic sinusitis
that initially had a CBF that was statistically less than the controls, had returned to a
CBF that was no different to the control subjects. Analysis of pre and postoperative
mucosal biopsies revealed a retum to a healthy state of ciliated epithelium, and also a
"reorientation ofpreviously disorganised cilia". The authors also assessed the
patterns of mucociliary flow and noted improvements in these at 6 weeks
postoperativelyl63J. In a rabbit model, Kennedy et al re-examined some of Hilding's
work and noted that widening of the middle meatus resulted in epithelial regeneration
but did not result in reorientation of mucociliary clearancel64]. Unfortunately, until
recently there has not been a suitable animal model for ESS so the specific effects of
ESS on sinusitis have not been studied in an animal ms¿s1[65J.
Clinical studies on human patients have also demonstrated the beneficial effects of
ESS on both the histopathological changes due to sinusitis and also on improving
mucociliary clearance. Hafner et al. measured both CBF and also mucociliary
transport time before and after ESS in patients with chronic rhinosinusitis, and
showed a significant improvement in mucociliary transport time after surgery t661.
Lund et al measured CBF in patients before and after ESS and again showed a
significant improvement after surgery. They also demonstrated an improvement in
subjective symptom scores but no improvement in rhino manometric assessment of
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nasal airflowl67]. In a series of 70 patients undergoing ESS for chronic sinusitis,
preoperative CBF values were shown to be signihcantly reduced compared to normal
subjects, but 6 months after surgery, signihcantly improved and had reached normal
values[68]. Ikeda used Technetium nuclear medicine scanning to show a significant
improvement in mucociliary transport rate after ESS, and the use of light and electron
microscopy revealed in increase in ciliated epithelium, and an improvement in ciliary
organisationl69]. In series of human patients undergoing ESS, Moriyama showed that
after atime period of 6 months, there was an almost complete return to normal
respiratory epithelium if the surgical injury had only been removal of the superficial
layers of tissue. lnspection by SEM at a time of 18 months post operatively revealed
normal reciliation of the epithelium. Úr contrast, when the surgical injury was a
complete removal of mucosa to expose bone, normal epithelium was not seen at 6
months, and at 18 months, although the epithelium appeared macroscopically normal,
it proved to be non ciliated when examined by SEyt70ì. Again, in a series of human
patients with chronic sinusitis, mucosal samples were taken preoperatively and 6
months postoperatively, examined with TEM (Transmission electron microscopy)
and compared. In the preoperative samples, the most notable finding was the paucity
of cilia on the epithelial cells. ln contrast, in the postoperative samples, the degree of
ciliation had returned to a normal healthy state in 75o/o of the patients, and the
remaining 25o/o, although there was no improvement, there was no worsening in the
degree of ciliationl71]. Asai et al examined mucociliary clearance as assessed by the
saccharin transport test, and correlated this with the endoscopic appearance of the
maxillary sinus mucosa. They noted a post ESS improvement in the saccharin
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transport time in the subjects whose sinus mucosa appeared most healthy. SEM
analysis was also performed on mucosal samples from those patients with the most
prolonged saccharin transport time and revealed an extensive loss o¡ 
"i1is,1721.
Kaluskar et a1., likewise measured saccharin transport time in patients pre and post
ESS and demonstrated an improvement ¿¡e¡ p55[731.
The Importance of Mucosal Healing
Now that we have considered the pathological processes behind chronic rhinosinusitis
and the principles and efhcacy of ESS in the management of sinus disease, we can
turn our attention to the vital arca of mucosal healing after surgery. In a canine
model, Hilding noted that when mucosal injuries were made, they were replaced by
scar tissue, and sometimes, even bone, which impeded mucociliary clearance, even
though they did possess some ciliated epitheliumÍlg'74l.In a rabbit model, Benninger
et al noted an incomplete regeneration of ciliated epithelium after complete removal
of the maxillary sinus mucosa via a Caldwell-Luc incision, with the proportion of the
cells in the operated sinus demonstrating ciliation of only 54%o of those on the control
side [75]. Shaw et al created endoscopic fulland pafüaTthickness injuries in a sheep
model. At day 84 post-operatively, only 80.7o/o of the partially injured surface had
reepithelialized, and only 64.90/o of the fully injured surface had reepithelialized. In
terms of reciliation at day 84 post-operatively, 68.4% reciliation had occurred in the
surfaces that had partial thickness injuries and only 33%o of the fully injured surface
showed reciliation. Interestingly, there ìù/ere no signifrcant differences in mucociliary
transport time between the two injury groups at day 84 and the baselins v¿luss[761.
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Shone et al examined the healing of nasal mucosa after ESS in human patients and
noted that it took up to three months for mucociliary clearance to improve, suggesting
a slow return to normal ¡rrç6sn[771.
Adhesions and Their Relevance to Sinus Surgery
The most common post operative complication encountered in the field of nasal and
sinus surgery is the occurrence of post operative adhesions, which are a result of
impaired healing, have serious clinical consequences, especially with regards to
fecuffence of disease and symptoms124,30,58,78,791. Brennan et al. carried out a
retrospective review of 479 cases, where an intranasal procedure was carried out on
the nasal septum, inferior turbinate, or both, and noted adhesion formation in30'6%o
to 36.2Yo of cases [80]. Tofffel reported that3Yo(4l patients) of a series of 1363
patients developed adhesions between the middle turbinate and lateral nasal wall, and
of these, 15 required revision swgery. This was despite the use of special stenting to
prevent these adhesions forming t561. Schaefer et al reported the formation of
adhesions between the lateral nasal wall and the middle turbinate in 60/o of their
patients, and these adhesions as one of the "most frequent and frustrating
complications" of ESS, which leads to obstruction to the natural mucociliary drainage
pathway from the ethmoid and maxillary sinuses, and would eventually lead to
si11¡ritis[¡o]. Levine reported an incidence rate of stenotic lesions of the maxillary
ostium of 6.8%o in a series of 250 patients, and 60%o of these patients required revision
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surgery[57]. In a series of 145 patients undergoing ESS, adhesions were seen in
tl.7%1581. Stammberger stated that if apposing areas of mucosa aÍe pressed together
and adherent, as occws with adhesions, then mucociliary transport of mucous from
those areas is interfered with and the resultant pooled mucous becomes an ideal area
for the growth of bacteria or virusesl24]. Given that the presence of inflammation
delays the return of normal epithelial coverage after surgery, the presence of active
infection and inflammation in the nasal mucosa may predispose patients to the
formation of post operative adhesions due to damage to the normal mucociliary
clearance system which may aid removal of post operative debris including blood
clots. The multiple cytokines and other bioactive agents[8lJ present due to the chronic
inflammatory state may also predispose to tissue changes characteristic to
inflammation such as fibrosis, and scarring, rather than regeneration of injured tissue
to its normal state.
Nasal Packing
The use of postoperative nasal packing is one technique by which surgeons have
attempted to reduce the incidence of adhesions. Since the advent of nasal surgery, the
use of nasal packing has been almost universal[82]' Packing has been used pre
operatively for the delivery of anaesthetic and vasoconstrictor agents, in order to
improve analgesia and minimise intraoperative haemorrhage[83, 84]. Post operatively
the nasal cavity has been packed for the purposes of haemostasis, provision of shape
and support after surgery, and for the prevention of adhesion formation [84, 85]. ltt
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those studies, little or no benefit was seen in terms of adhesion prevention, but
deleterious effects of packing were noted. In regards to postoperative packing,
patients report the pain and discomfort upon removal of their packs post operatively
as being one of the most unpleasant aspects of their surgery[82]' Infection' specihcally
toxic shock syndrome[86,87], ¡¿s also been described. In animal models, occlusion of
the maxillary sinus ostium with non absorbable packing has been performed to induce
a state of sinusitis in the animal [28], and in theory, this same process could occur
during the postoperative period if packing is used. In a study comparing the use of 4
tlpes of non-absorbable packing, BIPP gauze, Jellonet, Merocel and Telfa, the
authors assessed patient comfort, haemostasis and ease of removal. While in situ,
there were no significant differences between the materials, but there was
significantly less bleeding and discomfort on removal associated with the Telfa and
Jellonet as compared to the BIPP and Merocel. This was attributed to the non-
adherent surface characteristics of these materials, which allowed easy passage from
the nasal cavity[82]. Shaw et el demonstrated that the use of preoperative packing for
the delivery of local anaesthetic and a vasoconstrictor, consisting of either ribbon
gavze or neuropatties, resulted in a statistically significant reduction in intact ciliated
nasal epithelium of over 50%o as compared to the unpacked side. They made the
recommendation that the use of packing should be minimised, and if possible,
performed endoscopically to minimise trauma to the epithelium.[88]. Another study
looked at the use of Silastic splints to provide stability to the healing septum after
septoplasty, and also to prevent adhesions within the nasal cavity. This randomised
study showed no difference either in adhesion f'ormation or septal stability between
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the splinted and unsplinted group, but patients reported increased pain and discomfort
with the removal of the splints[85J.
A rec ently develop ed non-dis s olvable packin g matenal, polyvinylchloride
(Merocel@), has also been shown to have no beneficial effect of the healing of nasal
epithelium after injury. This study was performed in the sheep model[65], and
involved histological analysis of the regenerating mucosa and electron microscopic
analysis of reciliation patterns and ciliary maturity (Unpublished data). Interestingly,
this study showed no significant differences in terms of reciliation or
reepithelialisation between the two groups, contrasting with Shaw 
"1 
u1's[88] work
showing significant damage with the use of packing. However, the analysis for Shaw
et al's study was done after only a few days post removal of pack, while Mclntosh's
work considered the long term healing results. Nevertheless, if in the early post
operative period after the packs are Iemoved there is damage to the cilia and
epithelium and thus a disruption in mucociliary clearance, it would seem logical that
this may impact negatively on the healing of the sinuses after surgery. As can be seen
from these studies, the packing materials associated with nasal surgery have tended to
have been non absorbable in nature and required removal. In order to avoid the
various problems associated with these packs, attempts have been made to develop
absorbable nasal packs. [89J
Due to the occurrence of postoperative adhesions and scarring, and the poor results
obtained by some patients from their ESS, attempts are constantly being made to
develop interventions or techniques that will improve healing of nasal mucosa atter
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surgery to prevent these problems. The aim of this thesis was to examine to effect of
two therapeutic postoperative interventions on the healing process of nasal mucosa
and the formation of adhesions after ESS.
Hyaluronic Acid
Basic Science
The first of these interventions was the use of a newly developed absorbable
hyaluronic acid based nasal packing, Merogel@ (Xomed, Jacksonville Fl). In order to
understand the choice of this packing material for use after ESS, one must wrderstand
the important biological properties of hyaluronic acid. Hyaluronic acid is a linear
polysaccharide that is made up of units of glucoronic acid and N-acetyl glucosamine.
It is a naturally occurring substance that is present in all soft tissues in humans and
other higher organisms[gO]. It is found in particularly high concentrations in the
extracellular matrix of foetal wounds, and believed to play in important role in foetal
wound healingl9lJ. The main reason for the interest in hyaluronic acid is the nature of
foetal wound healing. Unlike in adults, foetal wound healing is characterised by rapid
progress, the lack of scar formation and fibrosis and the absence of an inflammatory
process[92J t93]. this results in essentially "perfect healing", that is, regeneration
rather than repair, with none of the derangement of structure and compromise of
function seen in adult wound healing.[94]. Studies in foetal wound healing have
demonstrated a paucity of the collagens usually associated with fibrosis, and an
abundance of hyaluronic acid in a well organised extracellular matrix. The collagens
present are well organised unlike the patterns seen in scars[95]. In regards to skin
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wounds, the foetal fibroblast appears to be the cell responsible for coordinating the
healing process[96J. The hyaluronic acid also appears to remain present in the wound
extracellular matrix for far longer than in adults, most likely due to the presence of
HASA (hyaluronic acid stimulating agent)[ga]. As yet, the exact mechanisms of foetal
wound healing, and the role of hyaluronic acid in the process is not understood.
However, it has been speculated that an extracellular matrix rich in hyaluronic acid
provides an environment that facilitates cell migration and proliferation, and also the
orderly deposition of appropriate amounts of collageç¡193,97,981. Hyaluronic acid may
also interact with inflammatory mediato¡5[99J, and has been shown to inhibit platelet
function including the platelet driven activation of inflammatory pathways[l00J.
Hyaluronic acid nasal packs (Merogel@)
There are numerous forrnulations of hyaluronic acid available, including solutions of
differing concentrations and a hyaluronic acid-carboxymethylcellulose film
(Seprafrlm @). 4 newly developed formulation of hyaluronic acid is Merogel@,
composed of an esterified hyaluronic acid compound. This process induces
functionalisation of carboxyl groups in the HA, which allows attachment of bioactive
compounds. This functional esterihed hyaluronic acid has been termed HYAFF.
HYAFF can then be manufactured into hbres or membranes, which in turn can be
made into different products. Freeze-drying then allows the manufacture of sponge
like materials like Merogel [90]. It is fully biodegradable, resorbable material that can
be easily manipulated while dry. Human trials of using this material as middle ear
packing after ear surgery have been performed, and have demonstrated decreased
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unresorbed packing matenal, improved hearing results and an absence on new bone
formation when compared to the traditional absorbable gelatine sponge used in ear
surgery[0l]. Due to its bioactive profile with potential pro-healing effects, and the
fact that it is dissolvable, Merogel@ is a potentially useful nasal packing material.
Hyaluronic acid and adhesions
A clinically significant aspect of tissue healing in which hyaluronic acid plays apart
is that of adhesion formation. The relevance of adhesions after nasal surgery has been
previously discussed but adhesions have been most commonly described in the
general surgical and gynaecologic surgical literature. An adhesion has been described
as being the result of 2 injured surfaces healing in contact with each o1¡"t[102]. 1¡s
rate of adhesion formation in abdominal and pelvic surgery has been quoted as being
between 67Yo and97o/o, and adhesions remain the most common cause of small bowel
obstruction in the western world, as well as being responsible for infertility and pelvic
pain. There is also the associated morbidity and mortality of the surgical procedures
sometime required to manage these symptoms. As will be discussed later, the use of
hyaluronic acid based material has been shown to decrease the incidence of adhesions
formation in these circumstancesl103, 104] [105, 106].
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IGF-I - Basic science
The other intervention that was examined was the incorporation of Insulin like
growth factor 1(IGF-1) into the hyaluronic acid based nasal packing. IGF-1, also
known as somatomedin C, is a polypeptide growth factor with known cell
proliferation and differentiation, metabolic and anti apoptotic propertiesll0Tl. It is one
of a group of growth factors whose activity has also been implicated in wound
healingF0Sl. In the setting of wound healing, IGF-1 is initially released from alpha
granules in platelets. It is then believed to help modulate activities of other bioactive
substancesl09]. 111 latter stages of wound healing, IGF-1 is believed to play a role in
macrophage function[109], and alveolar macrophages have been shown to express
IGF- 1 , which can then act to encourage fibroblast proliferation[ 
1 l0] . In the next stage,
IGF-I has been shown to be a powerful chemo attractant for fibroblasts but is the also
secreted by fibroblasts to act in an autocrine fashion to stimulate further fibroblasts
proliferation and then collagen synthesis[109' 1ll,1l2].IGF-1 has also been shown to
be involved with angiogenesis, an essential element of wound healingll12]. Work on
a bovine respiratory epithelial culture model, IGF-I was shown to be a powerful
chemo attractantfor respiratory epithelial cells, and about 1000 fold more effective
than insulin for this purpose[l13]. IGF-I has also been demonstrated to play a role in
the epitheli alizationof wounds. An in-vitro study on intestinal wound healing
revealed that IGF-1 had a significant beneficial effect on intestinal epithelial cell
migration during wound healing, and demonstrated the presence of IGF-1 receptor
mRNA in intestinal epithelium[l14]. 5¿s et al examined the effect of IGF-1 on
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human keratinocyte migration and showed a significant increase in speed of
migration with topical application of IGF- I in a cell culture -o¿.1[1 1 s].
In vitro work performed by our group on a series of growth factors including IGF-I,
IGF-2, and Epidermal growth factor (EGF) suggested IGF-1 would be the $owth
factor most likely to show benefit on nasal epithelium (Unpublished data). Human
IGF-I has been shown to be structurally almost identical to that of sheep IGF-I,
varying by only one amino acidll l6l. Work by our group using immunohistochemical
techniques has also demonstrated the presence of IGF-1 receptors in sheep nasal
mucosa (wrpublished data). The carrier vehicle for the IGF-1 was Merogel@, a
hyaluronic acid based packing material whose biological effects have been previously
characterised in the sheep modelll l7]. Incorporation of bioactive factors into
hyaluronic acid based materials has been previously described as a successful method
of delivery of these substances to the nasal mucosa[l18]. The IGF-I was incorporated
into the packing material at the time of manufacture and its bioavailability from the
pack was demonstrated by radioimmunoassay techniques (urpublished data).
Animal Models For Sinus Surgery
In order to study the effects of these therapeutic interventions, a suitable animal
model was needed. For many years, animal models have been used to study the effect
of surgical intervention on the nose and paranasal sinuses. In a series of classic
studies in a canine model, Hilding demonstrated that removal of maxillary sinus
mucosa led to the formation of scar tissue which impeded mucociliary clearance[191,
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andthatcould also lead to new bone formation within the scar tissue[74]. Ill 1989,
Kennedy reviewed this work in a rabbit model with similar findings of scar tissue
formation if there was complete removal of mucosa[64], andthese observations
regarding scar formation and bony regrowth have also been noted by other authors
using animal modelsll19] [120]. In a rabbit model, Benninger concluded that the
changes in sinus mucosa after surgery were detrimental to normal sinus function due
to a less than optimal number of seromucinous glands being present in the
regenerating mucosa, leading to increased mucous viscosity, and there was also an
absence of motile cilia. Electron microscopy also revealed decreased numbers of cilia
on the epithelium, but an increase in the number of structurally abnormal cilialls'
1211. ¡t-r the same rabbit model with induced sinusitis, Benninger et al. demonstrated
no difference in either patency rates, or gross and microscopic grading of mucosal
inflammation, in subjects who underwent either a middle meatal antrostomy or an
inferior meatal antrostomyl44]. Friedman and Toriumi also studied the effect of
inferior meatal windows on mucociliary clearance using a rabbit modell2l]. In a
canine model, Kass evaluated the use of KTP and argon lasers on nasal mucosa[l22].
Schenk carried out a number of studies in a canine model to demonstrate that surgery
on the nasofrontal duct in this area could lead to fibrosis and adhesions in this area
and occlusion of the drainage pathway of the frontal sinus [123, 124]. y¿ot¡ has also





The advent of endoscopic sinus surgery during the 1980 has necessitated a change in
the animal models used to investigate sinus disease. All of the work thus far
described has involved animals such as dogs, cats, rabbits and mice. These animals
however, are not suitable for performing endoscopic sinus surgery and evaluating its
effects, due to the size and shape of their nasal cavities. Gardiner described the use of
cadaveric sheep heads as a training model for endoscopic sinus surgeons due to the
size of the sheep nasal cavity and sinuses, and also the similarity shown to human
sinus anatomyll2T). Previous work has shown that the nasal mucosa of sheep is very
similar to that of humans in terms of both its physiological and histological
characteristics, and is a suitably analogous model to study the effects of intranasal
medications [128-130]. Based on this work, and after carrying out anatomical studies in
other animals such as cows and pigs, Shaw et al developed and validated a sheep
model for endoscopic sinus surgeryl65ì. This model involved a surgical
standardization procedure involving endoscopic removal of the middle turbinate
complex in order to improve access to the nasal cavity and sinuses. Middle
turbinectomy has been a somewhat controversial procedure in humans, with different
surgeons both advocating and discouraging its usell31,132l. However, in human
studies, no significant adverse effects on mucociliary clearance have been
demonstrats¿l29]. In the sheep model, Shaw et al. demonstrated no adverse effect on
the mucociliary transport of the adjacent mucosa. Detailed histological studies were
also performed in this model to document the temporal healing pattern of the nasal
epithelium after full and partial thickness injury[76J' using this model, Mclntosh et al
Page 4l
then studied the effect of a hyaluronic-acid based nasal pack on mucosal healingll l7l,
and demonstrated improved reepithelialisation of wounded tissue with the application
of the pack.
Oestrus ovus
Most of the animal studies already referred to have been carried out in healthy
animals. As, however, the majority of sinus surgery is carried out on patients with
diseased sinusesl6,7,24],¡¡suse of animal models to simulate the disease process is
important. The sheep model, the first one suitable for use with ESS, also has the
advantage of having a naturally occurring state of sinusitis. Sheep are subject to a
condition known as Oestrosis, a parasitic infestation of the nasal cavity and paranasal
sinuses with oestrLts ovLts, also known as the nasal bot flyt133l' This condition also
affects goats, ibex, argali, and also h*utrslt¡¿]. The nasal infestation is caused by the
larvae of the fly, which hatch from eggs that are laid in the nasal vestibule. The larvae
migrate to the paranasal sinusesll33, 135]. Ïts presence of these lawae induces a
clinical state of sinusitis, which is characterised by rhinitis and also, marked increases
in the number of eosinophils and mast cells in the nasal and paranasal sinus mucosa.
033, 136, 1371. ¡1a study comparing sheep infected with Oestrus ovus with control
subjects, the increase in the number of eosinophils in the mucosa was by a factor of
17 to 58 depending on the location of the biopsies within the nose and paranasal
sinuses, [138]. 1¡" notable increases in the numbers of these inflammatory cells
suggests that the botfly infestation induces a hlpersensitivity response in the
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sheepF36-t381, most probably due to salivary gland proteins from the Oestrus ovus
1¿rv¿e[139J.
Significance of Tissue Eosinophilia in Humans
In recent work on human sinusitis, significant tissue eosinophilia has been noted as a
dominant feature, and has been linked to the production of the inflammatory
mediators that may be responsible for the tissue damage in the mucosa of the nose
and paranasal sinuses that characterise this condition[3, 140, 141]. 1¡e1e has also been
shown to be a statistically significant link between the degree of tissue eosinophilia
and the severity of the sinus disease, as graded by the CT scan findings of the
patien{l42,1431. 1¡.rs the presence of an eosinophil driven sinusitis in the sheep
would closely parallel the condition of chronic sinusitis seen in human patients.
However, as with any new model, it was important to document the disease state
present and compare it with healthy controls to ensure that the sinusitis present would
accurately mimic the disease state in humans, and its effect on the sinus mucosa and
its healing after surgery.
Assessment of the Mucociliary System
As a final but important point, it is necessary to understand the techniques that are
used to assess the histological state of the nasal mucosa and the function of the
mucociliary clearance system, and then to evaluate the changes wrought by
therapeutic interventions.
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Ham made the initial observations of cilia in l677lqqJ, using a microscope.
However, the function observation that ciliated epithelium resulted in airway
mucociliary clearance was made in the 1830s, again with the aid of the
microscope[10, 145]. Since then, assessment of the integrity and function of the
mucociliary clearance system has been done using two basic categories of techniques;
static and dynamic studies. Static studies are essentially histological studies
performed via light microscopy and electron microscopy. Light microscopy is useful
for assessing reepithelialisation, epithelial height, cell density, and to some degree,
reciliationl117]. Light microscopy specimens can also be used for
immunohistochemical techniques, to examine the samples for the presence of
collagens, growth factor receptors, etc (Unpublished Data). On the other hand,
electron microscopy is useful to assess reciliation, ciliary maturity and structural
abnormalities[s0, 146]. Dynamic studies are those that provide physiological
information about mucociliary function, such as transport rate and ciliary beat
frequency, and involve the use of microscopes, photodiodes, soluble and insoluble
particles and radioisotope techniques I I 6, | 47 ].
Static Studies
Light Microscopy
Light microscopy is a well-established technique for the assessment of mucosal
samples for many years. In his classic work in the canine model, Hilding used light
microscopy to assess the state of the regenerating epithelium and the degree of
fibrosis and reciliation seenll9,74,148].In latter work on the effects of chronic
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sinusitis on sinus mucosa in experimental models, light microscopy was used by.
Jacob et al used light microscopy to characterise the nature of the inflammation in
their murine model of sinusitis. They specifically assessed epithelial thickness and
surface area, andalso performed cell counts, by using image analysis software[28].
Marks used light microscopy again to examine the inflammatory mucosa in his rabbit
model of sinusitis, but in a qualitative rather than a quantitative ¡u.¡isn[27ì. Light
microscopic techniques were used by Benninger[75] to assess the regeneration of
maxillary sinus mucosa after removal, and noted inflammatory changes in the
mucosa, as well as incomplete ciliary fetum, as did Kennedy, in his work on the
maxillary sinus in a rabbit model[64]. Czaja and McCaffrey utilised light microscopy
and Haematoxylin and eosin staining to examine the mucosal samples in their rabbit
model of chronic sinusitis, and documented the degree of inflammation seen, and also
the degree of reciliation, and then the improvement in these parameters after surgery
was performedl26,63l. h the sheep model of chronic rhinosinusitis, Shaw et al
characterised the healing process of nasal mucosa after full and partial thickness
injuries using light microscopy techniques. Samples underwent H&E staining, and
the percentage of the surface area of the mucosa that had reepithelialized with ciliated
epithelium, was calculated using image analysis software [76]. This same histological
technique was also used to assess the effect of middle turbinectomy on the
surrounding nasal mucosa[65], and also the effect of nasal packing on the mucosa[88].
Utilising the same sheep model, Mclntosh et al examined the effect of a hyaluronic
acid-based packing material on nasal mucosal healing. They assessed
reepithelialisation using the same protocol as Shaw et al, but also measured the
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epithelial height, again using ImageMASTER Pro image analysis software (Media
Cybernetics, Inc., Silver Spring, MD), and then calculated a relative epithelial height
based on the baseline epithelial height measurements taken at the time of wounding.
The degree of reciliation of the mucosa was also carried out using light microscopy
and the same image analysis software[l17]. The same analysis protocol and healtþ
sheep model was also used to evaluate the effects of a hyaluronic acid-based pack
impregnated with Insulin Like Growth Factor - 1 (IGF-l) on mucosal healing
(Unpublished Data). Based on these studies, light microscopic analysis of H&E
stained sections was utilised in the studies in this thesis for the evaluation of mucosal
reepithelialisation and epithelial height.
Electron Microscopy
Owing to the limitations of light microscopy to effectively visualise structures as
small as cilia, electron microscopy has been used extensively to study the structure of
cilia, the degree of ciliation of epithelium and the effect of sinus disease on cilia[149]'
Scanning electron microscopy is most useful for assessing the surface structure and
appearance of specimens, and in this way, is essentially a light microscopy with very
high magnification. Mauritzi et al.l41) and Mygind et al [150] used electron
microscopy techniques to describe the ultra-structural ciliary abnormalities that
occurred as a result of chronic sinusitis. In a study conducted on patients with chronic
sinusitis, Toskala et al. used scanning electron microscopy to examine mucosal
samples and compare them with samples from healthy patients, and noted that an
increased loss ofciliated cells, the presence ofnon ciliated cells, ciliary disorientation
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and ciliary abnormalities such as compound cilia and shortened cilia were all far
more characteristic of samples from diseased mucosa than from healthy patients[50J.
Benninger et al. described the effects that surgery could have on the nasal mucosa by
using electron microscopy to demonstrate increased ciliary structural abnormalities
and decreased numbers of cilia in the mucosa which regenerated after surgeryll2ll.
Czaga and McCaffrey utilised transmission electron microscopy (TEM) to document
the ciliary ultra structural abnormalities that occurred as a result of chronic sinusitis
in a rabbit model, and the correlated these with aberrations in ciliary beat frequency
(CBF). They then examined the efficacy that surgery had in reversing these
abnormalitiesl43]. Moriyama et al used scanning electron microscopy to assess the
effect that ESS and the subsequent resolution of sinus disease in human patients, had
on the both the degree of reciliation of the mucosa, and also on the frequency and
nature of the ciliary abnormalitiss[7ol. Shaw utilised scanning electron microscopy
and subsequent image analysis techniques to characterise the time course and degree
of reciliation of nasal mucosa after full and partial thickness injuries in a sheep model
[151]. ¡4çlntosh et al utilised the same SEM specimen processing and image analysis
protocol to assess the effects of a hyaluronic acid-based pack on the healing of nasal




Dynamic studies of mucociliary function are those that provide information about the
physiological functioning and efficacy of the mucociliary clearance system, either in
part or as a whole[16].
Insoluble Particle Tests
The initial observation about the motile nature of cilia, and of mucociliary flow were
made using simple light microscopy and samples of ciliated epithelium such as frog
çhse¡[145J, and this process is still used today[152-154]. From this work came the
observation that the surface layer of mucous, and accompanying particles was
transported over the bed of cilia. Based on this, the most basic techniques of studying
mucociliary transport developed. This involved placing insoluble, visible particles on
the surface of the mucosa and measuring the speed at which they moved. In the
seminal work describing the patterns of mucociliary clearance in the paranasal sinus
complex, Hilding used topically placed ink to visualise the patterns of clearance in a
canine model[l9]. Messerklinger placed India ink in the maxillary sinus of cadavers
immediately post death and used his observations to document the movement of the
ink from the floor of the sinus to the maxillary ostium.[22]. Shaw et al. used carbon
flecks to measure the effect that middle turbinectomy had on the mucociliary
clearance of surrounding mucosa in a sheep model, and also to assess the effect of
pafüal and full thickness epithelial injury on mucociliary transport. This involved the
placement of these particles on the mucosa under endoscopic guidance, and then
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recording the time it took for the particle to reach a predetermined location in the
nasal cavityIlí,15ll. Benninger et al. utilised ink dust to assess the efhcacy of the
mucociliary transport system in the regenerating mucosa in a rabbit model[75].
Particle tests however, require placement of particle within the sinuses or nasal
cavity, and then visualisation of their movement, and so can result in some morbidity
for human subjects. In the sheep model of sinusitis, the experimental protocol that
necessitated serial mucosal biopsies precluded the use of a soluble particle technique
to assess mucociliary function.
Ciliary Beat Frequency
The dynamic assessment technique utilized for the studies in this thesis was the
measurement of ciliary beat frequency (CBF). Although Martius, in 1844, estimated
CBF using a stroboscope, the study of CBF was pioneered by Proetz itr 1932[155],
and Lucas in 1933[ts0J, who observed the "metachronous beat sequences" and the
phenomenon of "wave like sequences", using a beam of reflected light and a
microscope. This method, however, did not provide quantifiable information. In
1962,Dalhm¿n s1¿1.[157] were able to accurately measure CBF using a photocell and
amplification. The basic principle behind this was the intemrption to abeamof light
caused by the movement of cilia was converted into a measurable signal by a
photoelectric cell. Further technical improvement were made to this technique over
the years, and Yager et al. used this method to measure CBF in brushings of human
respiratory epithelium which were obtained by brushing techniquell58]. Puchelle et
¿1. [ 159]in¡.oduced the use of fast Fourier transformation of the signal data. Since
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then, measurement of CBF has been used to assess the effect of various nasally
administered medications on ciliary frrnction, in a chicken embryo tracheal
lissusl160J, and also the effect of various concentrations of saline douching ¡ui¿[l61]
Wilson et al demonstrated a significant slowing of CBF in patients with chronic
sinusitis, as compared to healthy subjects, and concluded that this may be responsible
for the decreased mucociliary clearance observed in such patientsl162]. In a study
examining CBF measurements and SEM analysis of ciliation in human patients with
chronic sinusitis, Joki et al. demonstrated a correlation between the degree of ciliation
and ciliary orientation, and the CBF, with lower CBFs in patients who had poor
ciliation or disorientated cilia[163]. Tsang et al recommended measurement of CBF as
one of the simple and clinically applicable tests of mucociliary function that should
be performed in patients with bronchiectasis[1491. Measurement of CBF, however,
provides quantifiable data about only one aspect of mucociliary transport, namely the
frequency at which the cilia are beatingllí,1641, and does not provide information on
the nasal mucous. Despite this, Duchateau, in a study in healtþ humans,
demonstrated a strong correlation between CBF and mucociliary transport time as
assessed by both the saccharin test and insoluble dye techniques. This work suggested
that CBF was the most important determinant for mucociliary clearance [164]. peçe6
work by Boek et al. examined whether changes in CBF resulted in changes
mucociliary transport as measured by ee-Tc scanning. They concluded that changes in
CBF resulted in significant changes in mucociliary transport, and thus, CBF was a an
important determining factor in mucociliary transpo¡ ¡¿1s[1651. Conversely, in a study
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on patients with chronic sinusitis who underwent ESS, CBF and mucociliary
transport time as measured by the saccharin test, were noted preoperatively, and 6
months post-operatively. These results were also compared to normal healtþ
subjects. The patients were noted to have signifrcantly lower CBFs than healthy
subjects. After ESS, although there was a significant improvement in mucociliary
transport time, there was no improvement in CBF. The authors concluded that
patients with chronic sinusitis may have an underlying ciliary disorder which may
predispose them to sinusitis, and that since the CBF did not improve after surgery, the
resolution of symptoms in patients may be due to factors other than an improvement
in the health of the ciliated epithelium. Those factors included mucous viscoelasticity
or tethering[162J.
Summary
In summary, this study had 3 aims. The hrst was to document and validate the sheep
model of eosinophil driven sinusitis. The second was to assess the efficacy of a
hyaluronic acid based nasal pack on nasal mucosal healing after ESS in sheep with
eosinophilic chronic rhinosinusitis. The third aim was to assess the efficacy of IGF-1
incorporated into the hyaluronic acid based nasal packs on mucosal healing after ESS
in sheep with eosinophilic rhinosinusitis. In order to assess the effect of these
interventions on mucosal healing, light microscopy was the selected technique to
measure mucosal reepithelialisation and epithelial height, and electron microscopy
for assessment of mucosal reciliation. To perform a dynamic assessment of
mucociliary function, ciliary beat frequency \Mas measured.
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Methods and Materials
All procedures received approval from the Animal Ethics Committees at both the
Queen Elizabeth Hospital and the University of Adelaide. The subjects were managed
under the conditions set out in the NH&MRC guidelines for the ethical treatment of
animals.
'We 
considered that a25o/o improvement in reepithelialisation or reciliation due to the
application of either the nasal packing or the packing impregnated with IGF-I would
be deemed clinically significant. Based on this, a power study showed that a sample
size of 9 in each of these two groups, with a 5o/o test level would provide a power of
80%.
The subj ects for this series of studies were I 8 normal sheep. They were kept in an
outdoor animal holding and research facility for the duration of this study, and
transported to and from the animal laboratory as needed.
Standardisation Procedure
The initial standardisation procedure was performed as previously described by Shaw
e1¿1[65J. The subject was given a general anaesthetic involving IV Sodium
Pentobarbitone 60mg/m1,72 mL, to induce anaesthesia and facilitate intubation, and
then Halotharc lo/o-4o/o, and Oxygen were used to maintain anaesthesia. The subject
was then placed on a specially designed cradle that positioned the sheep in a supine
position with the nose lying in a vertical orientation. Swgical drapes were placed over
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the animal to ensure an aseptic technique. 3 puffs of Co-Phenylcaine forte spray
(Lignocaine Hydrochloride 50mg/m1(5%), Phenylephrine Hydrochloride 5mg/ml
(05%), Benzalkonium Chloride 0.lmg/ml, Paedpharm, 'WA, Australia) were placed
in each nostril. This was followed by 2nn of local anaesthetic solution, (2olo
Xylocaine, 1/80000 adrenaline) which was injectedvia a dental syringe, anteriorly
into the ridge of attachment of the middle turbinate on the lateral nasal wall. 6
neuropatties \Mere then soaked in a total of 2ml of l0o/o cocaine solution. On each
side, a neuropattie was placed above the middle turbinate, one rü/as placed below the
middle turbinate and one placed on the medial surface of the middle turbinate lying
between the turbinate and the nasal septum. All of the neuropatties v/ere placed lying
in a longitudinal orientation lying anterior to posterior. The patties were left in place
for 10 minutes. These procedures were performed to ensure adequate haemostasis
during the procedure and are analogous to the use of topical agents during ESS on
human patients.
The neuropatties were then removed and the nasal cavity was inspected using a 0
degree 4mm rigid Hopkins rod and a 30 degree 4mm Richards Sinuscope, connected
to a Storz Endovision cameÍa system and Sony PVM Trinitron Monitor. A Storz
Endovision light source and cable was used to provide illumination. Endoscopic
instruments were custom designed to suit the sheep nasal cavity and manufactured by
Micro France. Endoscopic turbinectomy scissors were then used to remove the
middle turbinate complex from the lateral nasal wall via careful dissection along the
ridge of attachment of the turbinate, under direct endoscopic vision. Care was taken
to avoid damage to either the lateral nasal wall or the nasal septum.
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Figure I
Figure 1 illustrates a coronal CT scan through the nasal cavity of the sheep
demonstrating the large middle turbinate complex that fills the nasal cavity.
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Figure 2
Figure 2 illustrates the appearance of the sheep nasal cavity after removal of the
middle turbinate complex.
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Initial haemostasis was then performed using local application of the previously
removed neuropatties, and if this proved insufficient, unipolar suction diathermy was
utilised. At the end of the procedure, the cavity was carefully inspected to ensure
haemostasis, the anaesthetic agents were turned off and the animal extubated. The
animals were kept in the holding facility of the animal laboratory for 3 days and
carefully monitored for any evidence of pain or distress, or any postoperative
bleeding. They were then returned to the animal holding facility (paddock) until their
next procedure.
Full Thickness Injury and Day 0 Baseline Biopsies
After a period of 28 days had elapsed, the subjects were returned to theatre for the
initial wounding procedure, again previously standardised and described 165'76' 
llll'
Once again, the cavity was initially inspected with the endoscope. A pair of
endoscopic biopsy forceps was then used to take samples of tissue from the lateral
nasal wall bilaterally after an initial mucosal incision and elevation using a Freer's
elevator. The procedures for processing these tissue samples will be discussed later.
A microdebrider fitted with a 4mm cutting blade (Xomed, Jacksonville Fl) was then
used to create a full thickness mucosal injury on the lateral nasal wall, in 2
longitudinal strips, above and below the ridge of previous attachment of the middle
turbinate. This procedure was then repeated on the other side. The sites of mucosal
injuries are marked on figure 3 with the red stars. A specially designed measuring
device was used intranasally, to ensute that the injury coÍlmenced at least 15mm
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from the aperture of the nostril, and extended posteriorly to about 10 mm from the
anterior aspect of the ethmoid terminal ridge.
In each individual subject, the exact dimensions of the injury and their relationship to
these fixed landmarks were documented. These measurements were then used to plan
the sites of future biopsies on Days 28,56,84 and \12, andthese were documented
on a planning sheet for each subject. On a side selected by computer randomisation,
either a 15mm x 50mm piece of hyaluronic acid based nasal packing material in 9 of
the sheep, or the same sized piece of packing impregnated with IGF-1 in the other 9,
was placed on the lateral nasal wall under endoscopic guidance. The other side was
left unpacked as a control. The position of the nasal packing is indicated by the white
crescents in figure 3.
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Figure 3
Figure 3 illustrates the sites of mucosal injuries and nasal packing in the sheep
nasal cavity.
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In order to simulate adjacent mucosal surface injuries, full thickness mucosal wounds
were created between the lateral nasal wall and the adjacent ethmoid terminal with
the microdebrider. Care was taken to minimise the damage to the delicate bone of the
ethmoid terminal, and to avoid dislocation and medialisation of the ethmoid terminal.
The ethmoid terminal or turbinate closely resembles the middle turbinate in humans'
It is a similar size and has the same proximity to the lateral nasal wall as the human







Figure 4 illustrates the appearance of the lateral nasal wall and the ethmoid
terminal; úhe site where adhesions were created
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Computer generated randomisation was used to select the side of the nose to be
packed. In each subject, a lcm x lcm piece of hyaluronic acid based packing, with or
without impregnated IGF-I, was placed between the two injured surfaces on the same
side where packing was placed on the lateral nasal wall, while the control side was
left unpacked. Packing impregnated with IGF-I was used in the same sheep in which
the IGF-1 impregnated packing was used to pack the injuries on the lateral nasal wall.
The subjects were observed in the animal laboratory for a period of 3 days, and then
transferred to an animal holding facility.
Day 28, 56,84 and 112 Biopsies
After a further period of 28 days, the animals were then returned to the animal
laboratory for their first post-injury biopsy. The biopsy was performed under
sedation, attained using Xylazene,20mgln7,0.2 ml via intramuscular injection. The
nasal cavity was then inspected using the rigid endoscope. The hrst sample taken was
a mucosal brushing for ciliary beat frequency. This technique will be described later.
The nasal cavity was then sprayed with Co-Phenylcaine forte for the purposes of
local anaesthesia. After allowing 2 minutes for this to take effect, a Freer's dissector
and biopsy forceps were then used to raised a small mucosal flap and then take a
mucosal biopsy from the area predetermined by the planning sheet. The exact site of
the biopsy was determined via the use of a custom designed measuring device under
endoscopic guidance. The brush cytology was taken from a separate area of the
wound. This procedure was then repeated on the other side. The subjects were then
examined endoscopically to ensure haemostasis. They were kept in the animal
laboratory for 3 days before retuming to the animal holding facility.
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This biopsy procedure was then repeated on Days 56,84, and ll2 post-injury.
After the final biopsies were performed, the subjects \Mere held in the animal holding
facility for a further 12 months, with the intention being to perform further biopsies at
this time to assess long term healing outcomes. Those results will form the basis of a
further paper and will not be discussed in this thesis.
Preparation and Analysis of Light Microscopy Specimens
The protocol for the processing of the light microscopy specimens was identical to
that previously described by Shaw et al[6s' 76] andMclntosh et al.[117]. After removal
from the subject, the sample was placed between 2layers of foam within a plastic
cassette, each with a unique cataloguing number assigned to it and labelled. A23-
gauge needle was used to manoeuvre the specimen into an optimum position. If there
was blood contaminating the specimen, it was washed off with 0.9% saline solution.
The cassettes were then placed in a l}Yo formaldehyde solution for a period of 3
hours. After this, they were transferred to a 70%o ethanol solution for storage. These
cassettes were then placed in a Tissue-Tek@ VIP Processor for overnight fixation.
The next morning, the specimens were removed and mounted in paraffin wax. After
this, the specimens were then placed in a refrigeration unit (<-4 degrees Celsius) for a
period of I hour. The frozen mounts were then sectioned using aLeica microtome set
to 4 microns, and mounted on glass microscope slides. The slides were allowed to dry
overnight in a heating unit, and then were stained with haematoxylin and eosin. After
being allowed to dry, cover slips were placed over the sections and secured with an
appropriate adhesive.
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Each slide was labelled with the specimen's catalogue number, which did not in any
way identify the subject, the side from which the specimen came, or the date of the
biopsy. In this way, the researcher was blinded when assessing the slides.
Using Image Pro Plus image analysis software, and a light microscope, digital images
were created from the slides, which were then used for analysis.
Assessment of Reepithelialisation
The degree of reepithelialisation in the healing tissue was determined by measuring
the length of visible surface tissue on the area analysed, and then the length covered
by epithelium, as illustrated in figures 6 and & 7. The o/o reepithelialized could then
be calculated. This was performed on the entire area of mucosal surface seen on the
images. This method of calculating reepithelialisation has previously validated and
published by Shaw and Mclntosh [76' ll7].
Page 64
Figure 6
Figure 6 A light micrograph of the nasal mucosal epithelium
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Figure 7
Figure 7 - The technique of assessing mucosal reepithelialisation.
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Assessment of Epithelial Height
Epithelial height was calculated using the same digital images used for measuring re-
epithelialisation. The epithelial height was the average distance between the apical
surface of the epithelium and the basement membrane, over the entire length of
mucosa analysed for the reepithelialisation measurements (see frgure 8).
The relative epithelial height was then calculated by comparing measurements at the
various time points to the baseline epithelial heights as measured at day O.Again, this
technique has been previously described[l17]. A student's T Test was used to analyse




X'igure 8 - Assessing epithelial height
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Preparation and Analysis of Electron Microscopy Specimens
Specimens were taken at days 0, 56 and 712 for electron microscopic assessment of
ciliary regeneration. After biopsy, the specimens were placed in a phosphate buffered
saline solution, and surface blood and mucous was carefully removed using a
sonication process. The specimens were then placed in a solution consistingof 4.0Yn
paraformaldehyde and 1.25o/o glutaraldehyde, phosphate buffered saline pH 7 .2' The
specimens were then stored at 4"C. Specimen fixation was then performed using an
automated processor. The specimens were dehydrated using serial strengths of
acetone and alcohol. The process involved a sequence of immersions in different
media; Osmium tetroxide, 70o/o ethanol, g0o/o ethanol, 95o/o ethanol,l00yo ethanol, a
mixture of 100% ethanol and 100% acetone in a proportion of 1:1, and then 100%
acetone. The specimens were then dried in a carbon dioxide critical point dryer and
then mounted on electron microscopy stubs. A final coating of gold and carbon was
then applied.
Digital images of the surface were then obtained using a Phillips Field Emission
Scanning Electron Microscope Excel 30, and these were then stored in a high
resolution TIFF format. These images were taken from 4 areas of surface mucosa on
each specimen, and at both 500x and 2000x magnification (see figure 9). AnalySIS
Pro@ (Soft Imaging Systems GmbH) (Version 3.00) image analysis software was
then used to calculate the degree of reciliation in the healing mucosa.
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The software allowed the images to be assessed on an intensity scale, and cilia proved
to be electron dense and thus bright as compared to the background that was less
intense. This intensity difference enabled calculation of the surface area of the
mucosa covered by cilia. These calculation were performed at 500x magnification,
and our group has previously validated this method of measurement by demonstrating
minimal inter and intra observer differences between 2 blinded researchers on 2
different occasions (wrpublished data). Guoet u1[166], and Clark s¡ a,1.1167), described
a similar method of assessing ciliary density using SEM and image analysis. A
Student's T-test was utilised to determine the relationship between mucosal
reciliation and the presence or absence ofnasal packing
Preparation and Analysis of CBF Specimens
The samples taken for CBF measurements were collected using a nasal brushing
techniques, previously well established in the literature from a planned area of the
wound. This non-invasive technique has been demonstrated to reliably sample the
ciliated epithelium of the nasal cavity, and can be tolerated without the use of local
anaesthetic.l41,158,162,168,169l. 1¡s samples were taken after the sheep were given
intramuscular sedation but prior to the application of any local anaesthetic. This was
due to the well known cilio-inhibitory effects that local anaesthetic preparations such
as cocaine and lignocaine, and decongestants such as ox1'metazoline, have been
shown to demonstrate with in-vivo -o¿"1.[169-172]. 6"t-t"ral anaesthetic agents such
as halothane have been shown to have significant effects on ciliary beat
frequencyll73-115]. As the day 0 baseline mucosal biopsies and lateral nasal wall
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injuries were performed while the sheep were under general anaesthesia, no basehne
CBF samples were taken at day 0. When the day 28 biopsies were performed using
intramuscular sedation, the baseline CBF samples were taken from an uninjured area
of lateral nasal wall mucosa to simulate day 0 baseline biopsies. A Cyto-brush
(Crown Scientific) was moistened in Ham's nutrient solution, and a brushing was
taken from the nasal mucosa. The position of these biopsies was predetermined using
the planning sheet for each subject, and localised intranasally using a measuring
device and endoscopic visualisation. The brush was then swirled in a specimen tube
containing the nutrient medium to dislodge the samples. These tubes were then sealed
and placed in a carbon dioxide incubator set at 37'C. The reason for this is that ciliary
activity has been shown to be extremely sensitive to temperature, with the optimum
temperature being between 30' and 40o C, essentially normal body temperature.
Temperatures below this range result in significant slowing of CBFII6, 176]. y¿i1¡i1 3
hours of sampling, CBF measurements were made. Previous work has demonstrated
that cilia remain viable and motile in appropriate nutrient solutions for approximately
34 ho*r[tu8, 169]. After the specimen tubes were agitated to provide a suspension of
cells, a I ml volume was pippetted from the tube onto a glass slide with a well. A
cover slip was placed over the top of the well, and sealed with silicon grease. The
slide was then placed on the stage of a Nikon Eclipse TE 30 phase contrast
microscope (Nikon Corporation, Tokyo). The stage was fitted with a Series 20
Chamber, model RC-26 (Warner Instrument Corporation) warming device that was
preset to 3J"C. The light source \Mas a Nikon Super High Pressure Mercury Lamp
(Nikon Corporation, Tokyo), and the signal from the microscope was processed via a
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Biopac Data Acquisitions System, Model MP 100 (Biopac Systems Inc., Santa
Barbara, Ca) and a PC. Under microscopic vision, areas of ciliated cells were
located, and CBF measurements were performed using a photodiode technique and
Fast Fourier transformation. A total of 10 randomly selected areas of ciliated cells
were measured for each side of each sheep, and the CBF averaged.
A Student's T-Test was used to determine the relationship between the CBF at
various time points and the use of nasal packing.
Assessment of Intranasal Adhesions
At the time of the day 28 biopsy, the nasal cavity was initially inspected using the
endoscope. At this time, the presence or absence of an adhesion between the ethmoid
terminal and the lateral nasal wall was noted, and the image of this was captured
using a Video Cassette Recorder attached to the Sony Camera system that provided
the endoscopic vision. This process was repeated at each of the biopsy time points.
Figure 10 illustrates an example of an adhesion, whereas figure 1 1 illustrates the
absence of an adhesion. 'We did not attempt to grade the adhesions based on size due
to the small sample size in this study
A Fischer's Exact Test was used to determine the relationship between the formation












The Effect of Inflammation On Mucosal Healing
Light Microscopic Analysis of Epithelial Healing
Reepithelialisation
Light microscopic analysis was performed to determine the effect of chronic sinusitis
on reepithelialisation of injured mucosa (Figure 72),by comparing the control
specimens taken from the 9 sheep with sinusitis that were treated with Merogel
packing, with the control specimens from a series of healthy sheep who were also
treated with Merogel packing. At all time points after day 28, there was a significant
difference between the degree of reepithelialisation of the two groups, with the
chronic sinusitis group showing far worse reepithelialisation; day 56 (34.3% vs. ,78.4
% þ<0.01)) and day S4 (59.1%vs.9l.9o/o (p<0.05)). At day 112 post injury, the
chronic sinusitis group showed only 65.3Yoreepithelialisation, whereas the healtþ
sheep attained 9 4.7 % reepithelialisation (p<0. 0 1 ).
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Re Epithelialisation
























Figure 12 illustrates the comparison of mucosal reepithelialisation between the
healthy sheep and those with sinusitis. (Mean +/- SEM)
Epithelial Height
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Epithelial height was measured, and then expressed relative to the baseline epithelial
height, in order to derive the relative epithelial height measurements (Figure 13). At
day 28,the relative epithelial height in the infested sheep was significantly gteater
than that of the healtþ sheep, (1.41 vs. 0.Sl (p<0.05)). At the latter time points of
days 56, 84 and ll2, the values in the healthy sheep were 0.90 at day 56,0.95 at day
84 and 0.93 at day ll2,while the values in the infested sheep were 1.03 at day 56,
l.l7 at day 84 and l.Q2 at day lL2. Therc was no statistically significant difference
between the two groups at any of these time points when these results were analysed
using a Student's T test.
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Figure 13 shows the comparison of relative epithelial heights (a comparison to
baseline) between the chronic sinusitis group and the healthy sheep. (Mean +i-
sEM)
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Scanning Electron Microscopic (SEM) analysis of Reciliation
The degree of reciliation in mucosal samples from the groups was determined using
SEM at 500x magnification (Figure 14). At day 56, there was no significant
difference between the two groups, but at day ll2, the chronic sinusitis goup
demonstrated36.g%o reciliation versus 76.65% reciliation in the control goup
þ<0.01). Although this was statistically signifrcant, we do not feel tha|aT0%ó
difference in ciliation would necessarily be clinically significant.
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Figure 14 represents the comparison in reciliation as assessed by SEM between
the chronic sinusitis group and the healthy group. (Mean +/- SEM)
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Figure 15 illustrates the degree of reepithelialisation noted in the control sides
compared to the sides packed with the hyaluronic acid. In the control group, the
percentage of the mucosa that had reepithelialized was 29 .43% at day 28, 34 .28%o at
day 56,62.77% atday 84 and 6530% at day ll2.In the sides packed with the
hyaluronic acid/IGF-l, the degree of reepithelialisation was 20.690/o at day 28,
45.93% at day 56,58.79yo at day 84 and 62.05% at day 112. There were no
statistically signiflrcant differences in mucosal reepithelialisation at any time point
between the 2 groups when analysed with a Student's T test, nor was there any trend,
























Figure L5 illustrates the degree of mucosal reepithelialisation in the two groups
post operatively. (Mean +/- SEM)
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Epithelial Height - Merogel
The relative epithelial height, as a measure of the thickness of the regenerating
epithelium, is illustrated in figure 16. In the control gouP, the values were 1.41 at
day 28, 1.03 at day 56, l.l7 at day 84 and 1.02 at day 7l2.In the Merogel group, the
values were 1.33 at day 26, 0.92 at day 56, 1.34 at day 84 and 0.99 at day ll2. There
were no significant differences at any time point between the sides treated with
Merogel packs and the control sides, nor was there any trend (Figure 16). Both
groups returned to preoperative epithelial heights by day 112 postoperatively.
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Figure 16
Figure 16 illustrates the relative epithelial height of the regenerating mucosa in




Electron microscopic analysis of the regenerating cilia revealed 61.77% reciliation at
day 56 and86.92Yo at day 112 inthe control grouP, compared to 64.960/o atday 56
and79.60Yo at ðay 172. At day ll2, there was a statistically significant difference
between the Merogel group (79.6%reciliation) compared to the control group
(86.9%), (p<0.01) (Figure 17).
l
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Figure L7 represents the degree of re-ciliation of the mucosa post operatively, as
assessed by electron microscopy. (Mean +/- SEM)
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Adhesion Formation - Merogel
On the control sides where adhesions were created, an adhesion rate of 22.22Yowas
noted, and this was consistent over all time points. In comparison, adhesions were
seen in 44.44% of the sides treated with the hyaluronic acid packs, but this difference
was not statistically signifrcant ûr>0.05). (Table 1)
Table 1
Table f. illustrates the rate of adhesion formation in the two groups





Effect of Hyaluronic Acid/IGF-l (Merogel/IGF-1) Packing on Mucosal Healing
Light Microscopic Analysis
Reepithelialisation - Merogel/IcF-l
Assessment of the degree of mucosal reepithelialisation in the sides packed with the
hyaluronic acid/IGF-1 packs compared to the control sides, by light microscopy, is
shown in Figure 18. For the control side, the levels of reepithelialisation at each time
point were 18% on day 28, 5I%o on day 56, 52 o/o on day 84 and 65 o/o on day 1 12 For
the sides packed with hyaluronic acid packs impregnated with IGF-I, the values were
17 o/o on day 28 , 38 o/o on day 56 , 7 I Yo on day 84 and 63 %o on day 1 1 2. There were
no statistically significant differences between the two goups at any time point when
analysed using a Student's T-Test. There was an obvious separation at day 84 with
the sides packed with the control sides demonstrating 52 o/o reepithelialisation
compared to ll o/o in the sides packed with hyaluronic acid/IGF-1 packs but this was
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Figure 18
Figure 18 illustrates the percentage surface area of the injured mucosa that had
reepithelialized zt Day 28, 56, 84 and 112 post-operatively. (Mean +/- SEM)
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Control Comparisons - Reepithelialisation - Merogel/IGF-l
The comparisons between the control groups for the sheep treated with Merogel/IGF-
I and those treated with Merogel alone are shown in figure 19. This comparison was
performed to ensure there was no systemic or enhanced local effect of the IGF-I on
the mucosa in the opposite nasal cavity. In the Merogel control group, the values
werc 29.43o/o at day 28, 34.28o/o at day 56, 62.770/0 at day 84 and 65.30% at day ll2.
In the Merogel/IGF-l control group, the values were 17.91Yo at day 28,51.1,7o/o at
day 56, 52.10% at day 84 and 64.60%. There lvere no statistically significant
differences noted between the two groups af arry time point when the results were
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Figure 19
Figure L9 illustrates the comparison between the control sides of the subjects
Treated with Merogel/IGF-l packs, and the control sides of those treated with
Merogel packs alone. (Mean +/- SEM)
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Epithelial Height - Merogel/IcF-l
In figure 20,therelative epithelial heights of the control group and the group treated
with MerogeVIGF-l are compared. For the control sides, the values for relative
epithelial height at eachtime point was 1.10 on day 28,0'96 on day 56,0.94 on day
84 and 1.10 on day ll2. For the sides packed with MerogeVIGF-1, the values were
1.10 on day 28,0.86 on day 56, 1.50 on day 84 and 0.98 on day I 12. There \¡/ere no
statistically significant differences noted between the two groups at any of the time
points post operatively when the datawas analysed using a Student's T Test, though




























Figure 20 illustrates the comparison between the relative epithelial heights of the
control groups and the Merogel/IGF-l group. (Mean +/- SEM).
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Control Comparisons - Epithelial Height - Merogel/IcF-l
Again, comparisons were made between the relative epithelial height measurements
of the Merogel/IGF-1 control group and a Merogel control groups to ensure there was
no systemic effect (Figure 21). The Merogel control values were 1 .41 at day 28, 1.03
at day 56, l.I7 at day 84 and 1.02 at day ll2. The comparative values of the
MerogeVIGF- I controls were I . 10 at day 28, 0.96 at day 56, 0.94 at day 84 and 0.99
at day 112. As with the comparison of reepithelialisation control values, there were
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Figure 21 illustrates the comparison of relative epithelial heights between the





Scanning Electron Microscopic Analysis
Reciliation - MerogeVIGF-l
Scanning electron microscopy was used to assess the degree of reciliation of the nasal
mucosa post operatively (Figure 22). At day 56, there was a statistically significant
decrease in reciliation in the MerogelilGF-l group versus the control grouP, 59'20%
vs.77 .68Vo þ<0.01; Student T Test). At day 112, this difference was still apparent

























Figure 22 illustrates the o/o of tllre mucosa that had undergone reciliation at the
various time points post operatively. (Mean +/- SEM)
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Control Comparison - Reciliation - Merogel/IGF-L
A comparison of the MerogeVIGF-l controls with a Merogel control group (Figure
23), revealed a significant difference at day 56 post operatively, demonstrating
79.07% reciliation in the MerogeVIGF-l controls, versus 67.71% ciliation in the
Merogel control group (p<0.01). At day 112 post operatively, there was no significant
difference between the groups. Although this difference atDay 56 is statistically
signifrcant (p < 0.05; Student's T test), we do not feel that an ll.3% difference in
reciliation of the regenerating epithelium would be clinically significant.
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Figure 23 depicts the comparison between the control sides of the sheep treated
with the Merogel/IGF-L packs and those of the sheep treated with the Merogel
packs alone. (Mean+/- SEM)
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Adhesion Formation - Merogel/IcF-l
The use of Merogel/IcF-1 packing material had no statistically significant effect of
the formation of adhesions þ>0.05; Student T test), with an adhesion formation rate
of 55 .57o/o in the unpacked sides, compared to 33 .33 Yo in tlrre packed sides (Table 2).
However, there was a trend towards decreased adhesion formation in the sides packed
with the Merogel/IGF-l packing material.
Table 2
Table 2 illustrates the rate of adhesion formation in the two groups.






Comparison of Merogel and Merogel/IGF-l
Light microscopic analysis
Reepithelialisation - Merogel vs MerogeUIGF'-l
A comparison or mucosal reepithelialisation was made between the sides treated with
Merogel and those heated with Merogel/IGF-l (Figure 24).The
reepithelialisation values for the Merogel sides were 20.69% at day 28,45.93%o at
day 56,58.79% atday 84 and 62.05% atday ll2.The values for the sides treated
withMerogel/IGF-l were 17.10Yoatday28,38.I3yoatday56,7l.06yoatday 84 and
63.49% at day 112. There were no statistically signifrcant differences between the
two groups atany time point þ > 0.05; Student T test)'
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Figure 24
Figure 24 - A comparison of the reepithelialisation 7o in the sides treated with
Merogel compared to those treated with Merogel/IGF-l ( Mean +/-SEM)
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Comparison - Merogel vs MerogeVIGF-l - Epithelial Height
Figure 25 illustrates the comparison of relative epithelial heights in the sides treated
With Merogel versus those treated with Merogel/IGF-l. The values for the sides
treated with Merogel were 1.33 at day 28,0.92 at day 56, 1.34 at day 84 and 0.99 at
day ll2. For the sides treated with Merogel/IGF-l, the values were 1 .03 at day 28,
0.86 at day 56,1.50 at day 84 and 0.98 at day 112. There were no significant
differences between the two groups at any time point (p>0.05 ; Student's T test)
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Figure 25
Figure 25 illustrates the comparison in relative epithelial height between the




Comparison - Merogel vs Merogel/IGF - Reciliation
Figure 26 illustrates the comparison of reciliation values in the sides treated with
Merogel, compared to those treated with Merogel/IGF-1. For the sides treated with
Merogel, the o/o of ciliated mucosa was 64.96%o at day 56 and 79 '60% at day Il2.
This was compared to values of 59.20Yo at day 56 and 69.20% at day I 12' There were
no statistically significant differences between these values at any of the time points
examined (p > 0.05; Student T test). However, there was a non-significant trend





















Figure 26 demonstrates the comparison of mucosal reepithelialisation in the
sides treated with Merogel and those treated with Merogel/IGF-l
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The Effect of Nasal Packing on The Ciliary Beat Frequency of The Regenerating
Nasal Mucosa
Ciliary Beat Frequency - Merogel
Figure 2'7 lllustrates the comparison between the mean ciliary beat frequency
measurements in the sides treated with hyaluronic acid packs and the control sides.
The baseline CBF value for the control group was 7.51Hzandfor the Merogel group,
6.67H2. The values for the control sides were 4.80}ir2 at day 56, 4.77H:2 at day 84 and
5.l6Wz at day 128, compared to 5.28H2 at day 56, 4.05H2 at day 84 and 6'28H2 at
day ll2. At no time point was there a statistically significant difference between the
two groups when the results were analysed using a Student's T test. At day 28, there
,was no measurable ciliary activity from any sample in either gfoup. At day 772,
neither group had returned to the preoperative ciliary beat frequency values.
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Figure 27 illustrates the effect of Merogel nasal packing on the CBF of the nasal
mucosa post operatively. (Mean +/- SEM)
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Ciliary Beat Frequency - Merogel/IGF-L
With regards to the MerogeVIGF-l packing, figure 28 illustrates the comparison with
the control sides. In the control sides, the value at day 56 was 3.94H2, l.35Hz at day
84 and 6.92If12 at day ll2.lnthe sides treated with Merogel/IGF-1, the values were
3.34H2 at day 56,2.70H2 at day 84 and 5.44IJ2 at day 7I2. At day I 12, this
difference was statistically significant (p<0.05; Student's T test), with the hyaluronic
acid/IGF-1 sides demonstrating a lesser CBF than the control sides, suggesting a
detrimental effect of the packing (Figure 28). There was no measurable ciliary
activity at day 28 in either group, and both groups had returned to their respective pre
operative CBF values of 6.78Hzin the control group and 5.55}{2 in the MerogeVIGF-
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Figure 28 illustrates the effect of the Merogel/IGF-l packing on the CBF of the
regenerating nasal epithelium. (Mean +/- SEM)
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Ciliary Beat Frequency - Merogel vs MerogeVIGF-l
The sides treated with hyaluronic acid packs ,were compared with those treated with
Merogel/IGF-l in figrue 29.T\e values for the hyaluronic acid sides were 5.28H2 at
day 56, 4.05lliI2 at day 84 and 6.28IJ2 at day ll2, compared to 3.34H2 at day 56,
2.70H2 at day 84 and 5.44H2 at day 112. There were no statistically significant
differences between the two gloups at any time points when the data was analysed
using a Student's T test, though there appeared to be a consistent but non significant
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Figure 29
Figure 29 illustrates the comparison between the effects of the hyaluronic acid-
based packs, and the hyaluronic acid/IGF-l packs, on the CBF of the healing
mucosa. (Mean +/- SEM)
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Ciliary Beat Frequency - Control Comparisons
In order to exclude a systemic or extended local effect of the IGF-I, comparisons
were made between the two control groups. The Merogel control values were 4.80H2
at day 56, 4.l7Hz at day 84 and 5.l6Hz at day 712, compared to 3.94H2 at day 56,
|35H2 at day 84 and 6.92H2 at day ll2 in the MerogeylcF- 1 sides. 'When the CBF
values were compared (Figure 30), there was a significant difference at day 84, with
the Merogel controls demonstrating increased CBF compared to the Merogel/IGF-l
controls (p<0.05; Student's T Test). However, the Merogel/IcF-1 controls returned to
their approximate pre-operative values of 6.l8Hz by day 112, while the Merogel
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Figure 30
Figure 30 illustrates the comparison between the CBFs of the control sides of the
Merogel group and the Merogel/IGF-l group. (Mean +/- SEM)
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Discussion
The Effect of Eosinophil Driven Sinusitis on Nasal Mucosal
Healing
In the sheep model, the presence of inflammation secondary to the Oestrous ovus
nasal parasite results in impaired mucosal healing. The injured mucosa showed
significantly slower reepithelialisation after day 28 as compared to healthy subjects;
day 56: 34.3%vs.78.4o/o (p<0.01), day 84: 59.1% vs. 91.9% (p<0.01). 5. At Day 172,
reepithelialisation is incomplete and significantly worse in inflamed tissue than in the
healthy sheep, with only 65.3% reepithelialisation compared to 94.1o/o in the healthy
sheep.
Numerous animal models of chronic sinusitis have been developed and described. In
some of Hilding's early work in a rabbit model, when bands of mucosa were removed
in the vicinity of the maxillary sinus ostium, they were replaced with scar tissue,
which the author speculated resulted in intemrption to mucociliary flow and
subsequent suppurationl19]. However, numerous further studies have been performed
with the specific aim of deliberately inducing a state of sinusitis, with ensuing
mucosal inflammation, in the experimental subjects. Hinni et al. created a rabbit
model of sinusitis by accessing the maxillary sinus via an external approach and
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instilling a bacterial solution into the sinus on one side after obstructing the sinus
ostium, and leaving the other side obstructed but uninfected. The presence of
obstruction alone did not lead to pathological changes, but the presence of infection
and obstruction lead to significant losses of viable ciliated epithelium, with over 86%
of the ciliated cells being non viable within 5 daysla4. Forsgren et al' also utilised a
rabbit model, and sacrihced the subjects at various time points and then studied the
entire sinus complex including the bone. They noted that after denudation of the sinus
epithelium, there was extensive replacement of this mucosa with connective and scar
tissue within a week of the injuryll19]. Rabbit models with sinusitis induced by
inoculation of the maxillary sinus with various bacterial agents have also been used to
study the effect of corticosteroidsl177], fibrin sealant containing antibiotics [45], the
nature of the immune response to the infection [178], and comparing computerised
tomography scanning and magnetic resonance imaging, in subjects with acute
sinusitisll79]. Jacob et al described a murine model created by the use of bacteria and
nasal packing into the nasal cavity[28]. This model utilised one side of the nose as a
control, and the other as the site of the nasal packing and bacterial inoculation. The
mucosal samples were analysed for epithelial height changes using image analysis
software and reported qualitative increases in epithelial height and cell counts as a
results of sinusitis. This study demonstrated that inoculation with Bacteroides fragilis
and obstruction of the maxillary sinus ostium with an insoluble nasal pack; Merocel
Nasal Sponge (Xomed Jacksonville, F1.), resulted in a localised chronic
rhinosinusitis. A similar model had been described previously but this involved only
intranasal inoculation ofbacterial solution via droplets placed in the outer nares, and
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then sacrifice of the animals at various time point and subsequent histological
studyll S0ì. This work revealed that intranasal administration of Streptococcus
pneumoniae induced an acute bacterial rhinosinusitis when assessed by tissue culture
and histological evidence of neutrophil infiltration. All of these animal models
allowed evaluation of the sinus mucosa at various time points via sacrifice, but unlike
the sheep model, did not permit serial biopsies to be taken from the same subject.
These sinusitis models have then been utilised further to study the effect of surgical
procedures. Benninger et al. induced sinusitis in a rabbit model via occlusion of the
maxillary sinus ostia, and then studied the effects of inferior antrostomy versus
middle meatal antrostomy on the progress of the sinusitis by measuring ostial
patency, and gross and histological assessment of the sinus mucosa for evidence of
inflammation. They noted that chronic inflammation lead to a loss of ciliated
epithelium but there was no significant difference between the two procedures with
regards to patency of the ostia or progression of the sinus disease[44]. Czaja et al.
demonstrated that middle meatal antrostomies performed in rabbits with
Streptococcus pneumoniae induced sinusitis, resulted in a retum to normal in ciliary
beat frequency, and a reversal of the histopathological changes which characterised
the infected mucosa[63].
Our model differs from previous discussed animal models of chronic sinusitis in two
fundamental ways. The sheep model is the only model described which is suitable for
the study of endoscopic surgical interventions on the nose and paranasal sinuses, and
the model in its healthy state has now been well described and studied 165,'76,88' 1171.
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Secondly, we have relied on a naturally occurring parasitic infestation, which induces
an eosinophilic driven inflammation of the nasal mucosa. Other sinusitis models
described have required the direct inoculation of infective organisms such as
Streptococcus pneumoniae into the maxillary sinus, which is then occluded [26], or
packing of the nasal cavity with a non-absorbable pack[28]' As our model requires no
such manipulations, it closely parallels chronic sinusitis seen in human patients.
An interesting hnding in our model was that atDay 28 post injury, the infested
subjects had a statistically significant increase in the relative thickness of the
regenerating epithelium as compared to the healthy subjects (1.41 vs. 0.081,
(p<0.01)). It is possible that this epithelial hyperplasia represents a derangement in
the normal healing process, possibly due to the various inflammatory mediators
present as a result of chronic sinusitis. Chronic sinusitis has been described as not
only being an infectious condition, but also a complex inflammatory disease with
multiple cytokines such as LL-4,IL-13 and IL-5, histamine, and leukotrienesl8l]. If
we examine work performed in other animal models of chronic sinusitis, specifically
the rabbit model, it has also been proposed that inflammatory processes secondary to
infection may impair tissue healing after injury V2l' czaja et al' 126l revealed loss of
ciliated epithelium, and the analysis of mucociliary function showed a decreased
ciliary beat frequency and disordered patterns of mucociliary transpo rtÍ261 . Similar
f,rndings regarding the mucosa and ciliary function have been demonstrated by other
authors in rabbit -o¿e1s[42J [44]. However, they did not comment on the epithelial
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thickness of the sinus epithelium during the healing process. Jacob et al. noted
signif,rcant epithelial thickening in their murine model of chronic sinusitis [28], though
in their study, mucosal injuries were not performed and the thickening was due to the
presence ofbacterial infection alone. Schlosser et al. also noted goblet cell
hyperplasia in their rabbit model of sinusitis but this again was due to the infective
state rather than healin g after swgery[45ì . In our subj ects, a signifrcantly thickened
regenerating mucosa seen in the infested sheep at day 28 post injury. We feel that the
increase in epithelial height in the infested sheep represents a derangement in the
normal healing process that is probably due to the pre-existing inflammatory state in
the injured tissue. It has been well documented that multiple bioactive factors are
present in the presence of active inflammation. These include interleukins, ICAM
molecules and growth factors. These substances may interact v/ith the normal
regenerative process resulting in the increased epithelial thickness noted in our study
[4,181-r85] [81]
With regards to the degree of reciliation seen in the regenerating mucosa, there was
no difference between the two groups at day 56, but at day ll2,thete \Mas a
significant difference between the two, with the chronic sinusitis group showing
86.9% reciliation versus 16.64% reciliation in the healthy group (p<0.01). As the
difference between the two groups is just over I0o/o, this result it is not likely that this
represents a clinically signif,rcant difference. Nevertheless, it is interesting that the
presence of inflammation did not have the same deleterious effect on reciliation that
it did on reepithelialisation, as the sheep showed far better degtees of reciliation than
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reepithelialisation at day Il2;86.9% reciliation, as comparedto 65.3Yo
reepithelialisation. This would suggest that although only 213 of the injwed surface
has reepithelialized, the epitheliumpresent is well ciliated.
In a rabbit model of sinusitis , Czaja and Montgomery utilised SEM to observe
improvements in epithelial ciliation after middle meatal antrostomies were
performed, but they did not quantify their result.[63J. Benninger et al. noted the
presence of normal ciliated epithelium in the maxillary sinuses of rabbits after a
Caldwell-Luc procedure was performed. This analysis was performed using light
microscopy but the degree of reciliation was not quantified[7s]. Keles et al used
transmission electron microscopy (TEM) to document the changes in the ciliated
epithelium in patients undergoing ESS. They noted "complete recovery" of ciliary
structural abnormalities in the epithelium after surgery, but again, did not quantify the
degree of reciliation[7l1. Moriyama et al used SEM to observe the changes in ciliation
after ESS in human patients, but once again, did not quantify their results and
described only the presence or absence of normal ciliated cells[70].
We cannot compare the functionality of the new epithelium in terms of mucociliary
clearance, as this was not assessed in both goups. However, measurements of CBF
were made in the chronic sinusitis sheep model and these can be discussed. At day 28
post operatively, there was no measurable ciliary activity in any sample, suggesting
that mucociliary clearance at that time would be severely impaired, if functional at
all. By day 56, there was measurable activity, but the relative CBF values indicated
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that from day 56, there was an increase in CBF up to day 112, where the CBF values
approached only 60Yo of their preoperative levels. This is consistent with previous
work in human subjects, which showed that it took 6 months for CBF values to reach
normal, healthy levels after ESS, with the most rapid improvements being from
months 4 to 6[68]. This was despite the mucosa appearing to be grossly normal and
healthy when subjected to endoscopic examination. As previously discussed, the
studies by Moriyama et al. and Keles et al. did not involve any analysis of ciliary
function at 6 months post op[70' 71]' Guo et al. demonstrated recovery of ciliated
epithelium after ESS but also commented that further work was needed to assess the
functionality of the ciliated epithelium[166]. ç"414 and McCaffrey examined the time
course of healing after middle meatal antrostomies were performed in a rabbit model
of chronic sinusitis, and importantly, measured CBF as well as mucociliary clearance
times as a functional assessment of the sinus mucosa. They noted that 6 weeks after
surgery, the mean CBF in their infected models, which had previously been
signilrcantly lower than that of controls, had recovered to ameaî CBF that was not
statistically different to healtþ controls. The increase in CBF correlated significantly
with an increase in the mucociliary clearance transport time[63]. Unfortunately, there
has been no previous work performed to directly measure the CBF of nasal mucosa
that has been wounded and then allowed to heal.
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Conclusion
In summary, the presence of the nasal parasite oestrous ovus incites an eosinophilic
driven sinusitis in the sheep model. In this model, there is significantly impaired
epithelial healing after full thickness mucosal injury as assessed by reepithelialisation
and compared to healtþ sheep. There also appears to be a derangement in the healing
process that results in an increased epithelial height in the regenerating mucosa. The
presence of inflammation does not however result in a clinically signifrcant
difference in mucosal reciliation when compared to healtþ sheep.
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The Effect of Hyaluronic Acid Based Nasal Packing (Merogel@) on
Nasal Mucosal Healing
In this sheep model of chronic rhinosinusitis, a dissolvable hyaluronic acid-based
pack (Merogel) did not confer any signifrcant improvement in mucosal healing after
full thickness injury at time points from day 28 up to day 112 post operatively when
assessed by reepithelialisation, and epithelial height. Both groups showed a steady
increase in surface reepithelialisation over the post-operative period with separation
apparent at each time point but no significant differences or consistent trend. By day
712, neither group had exceeded 650/o reepithelialisation, demonstrating that even 4
months after surgery, there was poor mucosal healing apparent. After an initial
increase in relative epithelial height in both groups at day 28,the relative heights
returned to an approximate value of 1.0 by day 712.
When the reciliation of the injured mucosa was considered, there was no significant
difference seen between the two groups at day 56. However, aI day ll2,therc was a
statistically significant difference in reciliation between the packed group and the
control groups (76.9% vs. 86.90/o, p<0.01) but the difference was small enough to not
be considered clinically significant.
The use of the hyaluronic acid based nasal packing had no significant effect on the
formation of intranasal adhesions in the model.
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These results are not consistent with previous studies that have investigated the effect
of hyaluronic acid on tissue healing. Numerous animal studies have been performed
which have demonstrated the benefit of hyaluronic acid on aspects of tissue healing.
In one study involving the harvest of foetal mouse forelimbs, wounds were created
and then sutured. The limbs were then kept in a cell culture medium, half with a high
concentration of hyalwonic acid and half with plain medium, for 7 days, and the
wounded tissue was then examined for its histological features. The wounds treated
with hyaluronic acid demonstrated no typical scar morphology and resembled healthy
tissue, while the control group demonstrated the characteristics of scar formatiq¡l186J.
In other work, the hyaluronic acid content in wounded tissue in foetal rabbits was
reduced using a hyaluronidase, and compared to controls, and the depleted wounds
were shown to have increased evidence of collagen deposition, fibrosis and
neoangioge¡esls[91J
Although there is strong evidence, described above, that hyaluronic acid can be
applied to attain a beneficial effect on wound healing, questions have raised as to
whether the nature of foetal wound healing is also dependent on the foetal
environment, especially amniotic fluid, or to factors specihc to foetal tissue such as
the concentration of hyaluronic acid in the extracellular matrix. An elegant study was
performed in which adult skin was grafted onto mouse foetuses in utero, and then
those areas v/ere wounded 40 days later. The wounded areas demonstrated adult type
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healing, suggesting that the amniotic fluid environment was not solely responsible for
foetal wound healing, and that intrinsic foetal tissue factors, including the
extracellular matrix, were important. 
'Work 
was also described where foetal tissue
transplanted to adults and then wounded, demonstrated foetal type healing despite
being in an adult environment tl871 t961. The authors concluded that their f,rndings
supported previous work that showed that application of exogenous hyaluronic acid
could not result in totally scarless healing. Despite these controversies, many further
studies in animal models have been performed to investigate the effect of hyaluronic
acid on aspects of healing.
King et al. created wounds within hamster cheek pouches, and treated them serially
with either topical application of Hyaluronic acid plus a carrier vehicle, or the carrier
vehicle alone. The wounds treated with hyaluronic acid healed more quickly and with
less extravasation of inflammatory compoundsll88]. Utilising a rat model, Hagberg et
al. used a topically applied hyaluronic acid solution to influence healing and adhesion
formation after flexor tendon sufgery. After tenotomy and tendon repair, either
Sodium hyaluronate solution in 3 different concentrations, or 0.9Yo saline was
injected to fill the tendon sheath. Each animal acted as its own control. After 15 days,
the harvested tendons were tested for range of motion and the force required for such
motion, the degree of adhesion formation and limitation to function were calculated.
The highest concentration sodium hyaluronate solution tested demonstrated a
significant decrease in the extent of adhesion formation, and importantly, no decrease
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in the tensile strength of the repaired ¡sn¿6n[1891. A similar concentration dependent
effect was seen when the abdominal cavity of rats was pre coated with hyaluronic
acid solutions of varying concentrations (0.1,0.25 and0.4yo, a control phosphate
buffered solution, and no solution at all),prior to a controlled caecal injury. When the
animals were examined 1 week later, the mean incidence of adhesions were
signifrcantly decreased in proportion to the increasing hyaluronic acid concentration,
and the number of rats with adhesions decreased from 89% in the control group to
50Yo inthe 0.4o/o hyaluronic acid group[190]. 4 concentration dependent benefit was
seen when hyaluronic acid was applied to rat tyrnpanic membrane perforations.
Perforations treated with hyaluronic acid healed more rapidly and with less scarring
than controls, and the higher the concentration of hyaluronic acid applied, the more
rapid the closure of the perforationl191J.
There has only been one previous comparable animal study examining the use of
hyaluronic acid based packs in the nasal cavity. In work performed in a healtþ sheep
model, Mclntosh et al. demonstrated that adissolvable hyaluronic acid-based pack
(Merogel@) had a significant beneficial effect on aspects of mucosal healing after full
thickness mucosal injuriesll17]. At day 84-post injury, there was a significant
improvement in reepithelialisation of the mucosa treated with hyaluronic acid nasal
packs, as compared to unpacked controls, suggesting more rapid healing. There was
also a signihcant improvement in epithelial maturity as assessed by epithelial height,
atDay 28 and day 56 post injury. This more rapid return to mature epithelium was
attributed to the presence of the hyaluronic acid its effects on cell differentiation and
Page 127
migrationll lTl. However, no difference in re-ciliation \Mas seen. úr our sheep model
of eosinophilic driven chronic sinusitis, the benehts of the hyaluronic acid pack were
not apparent. There was no significant difference in re-epithelialization, or epithelial
height between the packed and controlled sides. In this study, these parameters were
analysed with the same methodology used by Mclntosh et alll17] in the healthy sheep
model. 'We theorise that the lack of efficacy of the hyaluronic acid packing in this
studywas due to the presence of sinusitis and inflammation at the time of the injury
and during the subsequent healing process. The effect of this inflammation on
mucosal healing has previously been addressed in this discussion, and the same
factors that lead to poor healing in the presence of inflammation may also interact
with the hyaluronic acid to prevent it having a significant effect on healing. The
studies attesting to the efficacy of hyaluronic acid based substances in enhancing
healing, which have previously been referred to in this discussion, were not carried
out in the presence of infection and inflammation.
Reciliation was examined in addition to reepithelialisation and epithelial height as
cilia represent an essential component of the mucosa in regards to the function of
mucociliary clearance. The reepithelialisation of mucosal surfaces would be less
important in terms of function with the absence of ciliary return U0' ll7l. Again, the
only comparable work was the study performed by Mclntosh et al. in the healtþ
sheep model. In that work the use of hyaluronic acid-based packing did not result in
any significant difference in reciliation post operativelytl lTl. ¡t this model of
eosinophil driven sinusitis, there was a statistically signif,rcant difference in reciliation
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at day 112, this difference of 7 .3%o was too small to be deemed to be clinically
significant. Thus, as with Mclntosh's worklll1l,lhe hyaluronic acid packing had no
clinically si gnific ant effects on reciliation.
V/ith the advent of endoscopic sinus surgery, the use of packing has become more
controversial. Improvements in visualisation of the operative field, as well as
technological advances in haemostatic cautery devices have facilitated intraoperative
haemostasis. Although haemostatic packs are still used, there is also an increasing use
of smaller or dissolvable packs that arc targeted to a specific site.
Brennan[80] examined the use of polyurethane packing for the specific purpose of
splinting open the middle meatus after ESS to prevent adhesions forming between the
lateral nasal wall and middle turbinate. If adhesions form, they can lead to
obstruction of sinus drainage and further disease. The specific pack was called the
Boomerang Turbinate Glove and was designed with a splint portion to lie against the
nasal septum and separate it from the middle turbinate, and a glove portion that fitted
over the middle turbinate and prevented its contact with the lateral nasal wall. This
was left in place for 9 to 14 days post operatively in a series of 234 consecutive
patients, and oral antibiotic cover was given. The timing of the removal of the pack
was based on patient tolerance and comfort, and the traditional time period for which
nasal packing has been utilised post operatively. There was no control grouP, but the
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author reported an overall adhesion incidence of 1.3%o, compared to his historical
incidence rate of 5Yo in patients prior to 1þis ss¡ies[80J.
Toffel described a series of 3000 patients in which he used the Toffel Merocel
(polyvinyl acetate) Sinus-Nasal Pak @system. A small wedge of the material was
endoscopically placed between the middle turbinate remnant and lateral nasal wall,
and alarger antibiotic coated Merocel Sponge was placed lower down in the nose to
decrease septal oedema and swelling. Oral antibiotic cover was also given, and no
episodes of toxic shock syndrome were reported. The packing system required
removal 1 week post operatively with the patient given intravenous sedation, as this
was the amount of time that most patients were able to tolerate the packing. Again,
there was no control group for comparison. The study reported very high success
rates in terms of symptom control, but this was attributable to the entire surgical
procedure and follow up protocol, rather than just the packing system[56J.
If expansile nasal packs are left in situ for a number of days post-operatively the
expansion of the pack combined with the post-operative swelling of the tissues after
surgery may exert considerable pressure on the tissues. Granulation tissue may also
grow into the pores of the pack. Removal of such a pack may cause considerable
mucosal damage, pain and bleeding[82J, as well as damage to the underlying
epitheliuml88]. These concerns with non-absorbable packing have resulted in
increased interest in the use of dissolvable packing material. Fanous reported
excellent results with oxycel and surgicel packing after conventional nasal surgery, in
terms of both patient comfort and haemos¡¿sis[89]. More recently, a dissolvable
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hyaluronic acid-based pack (Merogel@, Medtronic Xomed, Jacksonville, Fl) has been
developed for use as nasal packing material. As well as the pro-healing activities of
hyaluronic acid that have previously been discussed, hyaluronic acid is also believed
to possess bacteriostatic effects which may prove beneficial to prevent postoperative
infectionsll92] andreduce the need for prophylactic antibiotics. It has the advantages
of being highly biocompatible as it is a naturally occurring substance in the body and
it dissolves in the post-operative period, which makes it ideal for use as a nasal
packlloll.
In an attempt to reduce adhesion formation in other areas of the body, a number of
solid hyaluronic acid based substances have been developed for both animal and
human trials. In a randomised blinded control trial in a rabbit model, Seprafilm, a
hyaluronic acid and carboxyrnethylcellulose film, was topically applied at the time of
surgery to the injuries, a myotomy, an rÍìrepaired myotomy, or a repaired enterotomy,
created on the surface on the bowel. At a period of 14 days post operatively, after
which time the Seprahlm had been completely absorbed, a surgeon blinded to the
previous use of Seprahlm performed a repeat laparotomy. There was both a clinically
and statistically signif,rcant decrease in the incidence of adhesion formation in the
subjects treated with Seprafilm as compared to controls (6.6% vs. 30 %o and 6.60/o vs.
33o/o for repaired and unrepaired myotomies respectively)l193ì. Similar signif,rcant
benefits for a hyaluronic acid carboxymethylcellulose membrane have been shown in
an equine model involving small bowel injury (100% adhesions in controls vs.20o/o
in treatment group)tl9al, and also in a rat model examining adhesion formation after
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laser induced injury to the uterine 666[195J. Úr a similar rat model involving uterine
horn injuries, a hyaluronic acid solid frlm significantly reduced adhesion formation
(43%(HA) vs 88%(Control) after excisional but not electrocautery injuriesll02l. None
of these studies reported any adverse incidents attributable to the use of hyaluronic
acid or its derivative compounds. There have been a number of recent animal studies
that have examined the effect of Merogel on mucosal healing in the nasal cavity.
Maccabee et al. studied the effect of Merogel packing in a rabbit model, where the
maxillary sinuses were completely stripped of mucosa. They noted extensive fibrosis
within the regenerating epithelium, loss of the normal mucociliary surface epithelium
and Merogel fibres being incorporated into the new mucosa. Their conclusion was
that mucosal healing may be impaired by Merogel. However, their biopsies were
taken 14 days after the mucosal injury was created, and may represent and early
tissue responsel I 96] . As our initial biopsies were taken at day 28, we cannot comment
on the early phases nasal mucosal healing in the presence of Merogel In a murine
model, Jacob et al. noted that implants of Merogel resulted in new bone formation in
the nasal cavities of their subjects, as well as on calvarial bone after subcutaneous
implantation. These results suggested that Merogel may induce neo-osteogenesis
when in contact with damaged, regenerating bone[197]. This may possibly have
clinical implications when Merogel is used in the clinical situation in the presence of
exposed bone in the sinonasal region after full thickness mucosal injuries. There have
however, been no previous studies in an animal model of intranasal adhesions, nor of
the effects of Merogel on healing after ESS, and in this respect, our work represents
the first study of its type.
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In addition to the animal studies described, there have also been numerous clinical
trials in human patients. These have been in gynaecological and abdominal surgery,
as well as in nasal surgery. In a blinded, randomised, prospective and multicentre
clinical trial involving727 female patients, the efficacy of Seprafilm at preventing
adhesions after gynaecological surgery was examined. All patients underwent the
procedure of myomectomy, and baseline grading of adhesions present was made. At
the end of surgery, the patients were randomised to either the Seprafilm group or the
control group. The Seprafilm group had a sheet of Seprafilm placed on the posterior
surface of the uterus and wrapped anteriorly to ensure that all incisions were covered.
All patients underwent a 2nd look laparotomy at amean of 23 +l- 2 days after the
initial sugery. A video recording was made of this procedure. An independent
gynaecologic surgeon who was blinded to the treatment goup then viewed the
recordings and graded the adhesions according to a scale. This grading was then
compared to that at the initial surgery. The number of sites of adhesion to the uterus
was signihcantly lower in the Seprafilm treatment group than the control group (4.98
vs 7.88), and the mean adhesion severity score and mean area of adhesions were also
significantly higher in the control group. Importantly, no adverse effects or increases
in adhesion formation \ryere seen after the use of Seprafilm [106]. ¡1 another
prospective study involving 183 patients undergoing colonic resection and ileal
pouch-anal anastomosis with diverting loop ileostomy, subjects were randomised into
receiving a hyaluronic acid/carboxynethylcellulose film placed under the incision
and above the peritoneum, or having a standard closure. At the ileostomy closure
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procedure 8 to 12 weeks later, the abdominal cavity was examined for incisions under
the incision. Of the subjects treated with Hyaluronic acid, 49o/ohad adhesions
compared to 94o/o of the controls. Dense adhesions were observed in 58% of the
controls, compared to l5o/o of the treated subjects. In the control group, adhesions
involved a mean of 630/o of the incision length, as opposed to 23o/o of the treatment
group. These differences were all statistically significant. There were also no
statistically signif,rcant differences in adverse effects between the two groupsl198].
With specific regards to nasal surgery, in a clinical trial on 10 human subjects, 1
randomly chosen side of the nose was left unpacked while the other side was packed
with a hyaluronic acid-based pack (Supragel Sinus (hylan B)). The packing was
shown have significant beneficial effects in terms of synechiae, stenosis of the middle
meatus, mucosal regeneration and subjective measures such as nasal pain and
congestion, when compared to no packing[199J. There has also been a human trial
conducted in the use of a hyaluronic acid based cream (Rhinogen) to enhance post op
mucosal healing after ESS. This was compared to H.E.C. ointment and demonstrated
to have a significant benefit in improvements in nasal airflow, crust formation and the
condition of the nasal mucosa[2OO]. In a study comparing the use of Merogel
toGelfilm(Upjohn Corp'), an absorbable collagen based material, for middle meatal
stenting in 100 patients after ESS, Catalano and Roffman demonstrated a
significantly decreased occurrence of middle meatal adhesions. They also noted that
Merogel remained in situ for a significantly longer period of time than Gelfilm, There
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was, however, no control group with which to make comparisons, but no adhesions
\ryere seen in the sides treated with Merogel. In contrast to these three studies, Miller
et al. examined the effect of Merogel nasal packing on wound healing in the nasal
cavity after ESS, in a blinded randomised controlled trial in 37 patients. The patients
were followed up for 8 weeks after their surgery, and the use of the Merogel packing
was not found to confer any significant benefits in terms of either reduction of
adhesion formation, infection 6¡ 6s¿sm¿[20 I ].
In our study, the Merogel@ nasal packing was not intended to be haemostatic or to
provide support, but rather, was being used to promote healing by producing an
environment rich in hyaluronic acid and also, to deliver a growth factor to the
regenerating tissue. It was hoped that the use of this pack would result in faster and
more complete healing, and as a consequence, decrease the formation of adhesions
between the injured surfaces. In contrast to three of the human trials discussed above,
and the numerous animal studies and human clinical trials conducted with other
forms of hyaluronic acid, in the sheep model of chronic eosinophil driven sinusitis,
the hyaluronic acid based packing demonstrated no beneficial effect with regards to
adhesion formation. Our results however, concurred with study by Miller e1 ¿1.[201]
that demonstrated no beneficial effect of Merogel on adhesion formation. We did not
note any incorporation of Gelfoam fibres into the regenerating mucosa, as noted by
Maccabee e¡ ¿1.[196J, and as we did not take samples to study neo-osteogenesis, we
cannot comment on this, nor make comparisons with the work by Jacob 
"¡ 
u1ll91l.
The adhesion rate in the control sides was 22.22% (219),wh1le in the sides packed
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with hyaluronic acid based packs, the rate was 44.44o/o(a/9). Although these results
suggest that the use of the hyaluronic acid based packs was detrimental in terms of
adhesion formation, the difference was not statistically significant so this conclusion
cannot be drawn. The small number of subjects in this study may have contributed to
this result, and so meaningful conclusions cannot be reached about the eff,rcacy of
hyaluronic acid packs in preventing postoperative adhesions in this model until a
larger series has been performed.
Ciliary beat frequency (CBF) was also examined as a means of functional assessment
of the ciliated epithelium. At no time point post operatively was there any significant
difference between the control sides and the sides packed with the hyaluronic acid
based packing. At day 28, there was no measurable ciliary activity from any
specimen in either group, suggesting that the regenerating mucosa possessed no
active cilia, and thus an absence of mucociliary clearance function. At day 7I2, thete
appeared to be a separation between the two groups in favour of the sides treated with
the packing, but this was not statistically significant. Neither group had attained their
preoperative CBF values by day 112. Relative CBFs were calculated by comparing
the CBF values at eachtime point to the baseline preoperative CBF values, and again,
there were no significant differences at any time point. There appeared to be a trend
toward increased relative CBFs in the sides treated with the hyaluronic acid based
packing. In a study using cultured sheep tracheal cells, topical application of
hyaluronic acid resulted in a signif,rcant increase in CBF after 7 days in culture,
though it had no effect prior to that time point. The authors hypothesised that this was
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due to the binding of the hyaluronic acid to a cell surface receptor[202]. 1¡s¡s ¡45
been no other work conducted to examine the effect of hyaluronic acid on the
mucociliary clearance system in either an animal model or in human patients.
However, its well documented beneficial effects on tissue healing, which have
previously been discussed, would suggest that it would also have beneficial effects on
nasal mucosal healing, and this has in fact been demonstrated in a healtþ sheep
model[l17]. It would seem logical that improved epithelial healing would also result
in improved function of that epithelium and thus a beneficial effect on ciliary
function would be expected. However, in both the healthy sheep model, and in this
sheep model of sinusitis, the hyaluronic acid packing conferred no benefit in terms of
reciliation of the mucosall17]. Studies on CBF in a healtþ sheep model have not
been performed, so it may be that the presence of ongoing inflammation in the
sinusitis model prevented the hyaluronic acid from having an effect on CBF. Further
work needs to be performed to determine whether the lack of efficacy on CBF is an
inherent property of the hyaluronic acid, or as a result of its inability to work
effectively in a chronic inflammatory state.
We attribute the lack of efhcacy of the hyaluronic acid-based packs in influencing
postoperative healing, to the ongoing presence of the oestrous ovus infestation and
the ensuing inflammatoly response. Abnormal histological featuresl26'28' 
441¡uu"
been documented in the presence of infection and inflammation, and section 1 of the
results in this thesis has discussed the effects of inflammation on mucosal healing.
The milieu of inflammatory factors and bioactive substances may interact with the
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hyaluronic acid and interfere with its possible beneficial healing effects, and indeed,
there is some evidence for this. In a murine macrophage culture model, hyaluronic
acid induced the production of IGF-1 via its interaction with the CD44 surface
activation model. This IGF-1 is thought to play a role in pulmonary fibrosis, both by
directly promoting fibroblast proliferation, and via its action on tumour necrosis
factor aþha (TNF-cr), which in turn is involved in fibrosis and granuloma
formation[203]. On the other hand, the clinical state of sinusitis has been shown to
decrease the relative concentration of hyaluronic acid in the extra cellula¡ ¡¡¡a¡1i71204)
In this study, the nasal bots were not removed at the time of initial surgery, nor were
the sheep given appropriate pharmaceutical treatment for their infestation, thus
resulting in an ongoing inflammatory state during the healing process.
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Conclusion - Merogel
In the sheep model of chronic sinusitis, the use of a hyaluronic acid based nasal pack
(Merogel) conferred no beneficial effects on mucosal healing after ESS, as assessed
by mucosal reepithelialisation, relative epithelial height, reciliation, measurement of
CBF or prevention of adhesion formation
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The Effect of a hyaluronic acid-based pack impregnated with
Insulin-like growth factor 1, on nasal mucosal healing.
This study has demonstrated that in a sheep model of chronic sinusitis, a Merogel
pack impregnated with IGF-I had no beneficial effects on nasal mucosal healing after
full thickness injury, as assessed by reepithelialisation of the injured areas, ot in
regards to the relative epithelial height of the regenerating epithelium. The mucosa
treated with Merogel/IGF-l also demonstrated no significant improvement in healing
when compared to the mucosa treated with Merogel alone.
Numerous studies have demonstrated beneficial effects of topically applied IGF-I on
tissue healing. In a murine model, Menetrey et al. created wounds in muscle and
treated them topically with IGF-1. They noted a significant improvement in healing
and increased tetanus and fast twitch muscle strengths when compared to
.otr¡.o1.[205]. In a rat model, Toung et al. used topically applied IGF-I in a collagen
medium to attempt to improve healing of bony nasal defects. ln comparison to
controls treated with the collagen medium alone, the regenerating bone in the rats
treated with the IGF-1 demonstrated signihcantly increased bone density[206].
Accelerated healing due to topical IGF-1 application was noted in a cell culture
model of rabbit gastric epithelium[2071, aîd similar effects were seen in the healing of
colonic anastomoses in a rat ms¿e1[208J, both in terms of rate of repair and
anastomotic shength.
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Conversely, some authors have demonstrated no def,rnite beneficial effect from the
topical application of IGF 1. In a porcine model, topical IGF-I had no significant
effect on the healing of partial thickness excisional.ù¡ounds[209]. Further studies on
partial thickness skin wounds in a porcine model demonstrated that recombinant IGF-
1 alone had no significant effect on epidermal thickness, though in combination with
recombinant platelet-derived growth factor (PDGF), it did have a significant positive
effect on connective tissue content and collagen maturity, though this was in the
absence of inflamm¿1isn[108]. Based on this work, which suggested that IGF-1 alone
did not influence wound healing, IGF-1 and IGF Binding protein 1, in an emulsified
collagen medium, were applied locally to wounded muscles in arat model. In the
subjects treated with the combination, there was a significant increase in the peak
breaking strength of the healing muscle at7 days post wounding, as compared to
control subjects, which were treated with IGF-1 alone. A similar significant
difference was seen in rats treated with the combination treatment compared with
those treated with the collagen medium alone. In subjects treated with IGF-I alone,
and compared to controls that were treated only with the collagen medium, there was
no difference in peak breaking strengthsl210]. This work suggested that for effective
biological activity, an appropriate binding protein was needed if IGF-I was topically
applied. The authors theorised that binding proteins may protect the IGF-I from the
degrading effects of proteases, which are present in significant quantities in the
wound environment, by modulating such protease activity. They also commented that
slow release formulations of growth factors such as epidermal growth factor are
required for clinical efficacy when applied topically to wounds, due to a steady state
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model of growth factor receptor occupancy, and this model may well apply for
optimal activity of IGF-I[210]. The availability of the therapeutic growth factor is
very important, as it has been shown that a major problem with the use of growth
factors to enhance wound healing has been poor delivery and retention of the growth
factors at the desired site of actionl211]. This would be another potential advantage of
delivery of growth factors via the hyaluronic acid-based pack as we have shown this
pack remains adherent to the wounded nasal mucosa and dissolves slowly over a
period of 14 daysll17]. g* group has characterised the time course of the release of
IGF-I from the Merogel packing over a 5-day period, and demonstrated a release of
5lYo of the total amount impregnated (Unpublished data). Other authors have also
demonstrated that an esterified derivative of hyaluronic acid, in a microsphere form,
\¡/as a useful and efficacious method of drug delivery via the transmucos¿1 1e¡¿e [118],
In work conducted in a healtþ sheep model, using an identical experimental
protocol, Mclntosh et al. showed that IGF-I incorporated into a hyaluronic acid-
based nasal pack had a beneficial effect on tissue healing in the normal sheep without
sinusitis. At day 28 post operatively, Sgo/o of the injured surface treated with the
hyaluronic acid/IGF-l packing had reepithelialized as comparedto 44Yo in the control
areas (p<0.05) (Unpublished Data). This contrasts sharply with our findings that the
hyaluronic acid/IGF-1 packing had no effect whatsoever on reepithelialisation or
epithelial height. As the only difference between the two studies was the presence of
the eosinophil driven sinusitis in our model, we must conclude that the presence of
the inflammatory state and its associated mediators lead to the lack of efficacy of the
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IGF-I. If this situation is compared to that found in patients undergoing surgery for
chronic sinusitis, the inflammatory stimulus is usually removed at the time of surgery
with removal of the pus and infected material from the sinuses and by the
administration of antibiotics at the time of induction of anaesthesia. In the sheep
model used for this study, the infection with oestrous ovzs continued during the
healing process thereby simulating the healing of nasal epithelium in an ongoing
environment of continued inflammation. This may have had a detrimental effect on
the possible benefits of application of the IGFl impregnated hyaluronic acid.
With regards to reciliation of the epithelium as assessed by scaruring electron
microscopy, the hyaluronic acid/IGF-l packs had a detrimental effect on reciliation as
compared to controls at both time points post operatively; 59.20% vs. 77 .680/o at day
56 (p<0.01), and 68.700/ovs.87 .26Yo at day 112 (p<0.01). Interestingly, there was no
signihcant difference in reciliation between the sides treated with Merogel and those
treated with Merogel/IGF-1.
A vital issue in the discussion of wound healing after ESS is reciliation of the nasal
and sinus mucosa. Ciliated epithelium is necessary for the function of mucociliary
clearance, which is vital for the natural drainage system of the paranasal sinuses[28].
Ciliary regeneration in the healing mucosa has been described as the "most important
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requirement for successful surgery"l7O]. Using scanning electron microscopic
analysis of samples from human patients undergoing ESS, Moriyama et al
demonstrated a return to normal ciliated epithelium 6 months after surgery if only
mucosa was excised, but minimal reciliation at 18 months post operatively if mucosa
was strþped to bone. Effectively, this meant that the healed mucosa, though
appearing normal when inspected clinically, was in fact non fi.urctional due to the lack
of cilial7O]. In this study, at all time points post operatively, there was signif,rcantly
worse mucosal reciliation in the areas treated with IGF-1 as compared to controls.
This is in sharp contrast to Mclntosh et al's results in a healthy sheep model. They
demonstrated no significant difference between controls and mucosa treated with the
hyaluronic acid/IGF-1 packs in terms of reciliation as assessed by electron
microscopy. This is also in contrast to the in vitro work performed by Mclntosh et al.
which demonstrated that topical IGF-I had a beneficial effect on respiratory epithelial
wound healing in a cell culture model and scratch wound assay (Unpublished Data).
In the earlier section of this study, we examined the effect hyaluronic acid-based
packs had on mucosal healing in the sheep model of chronic sinusitis, and found a
statistically significant worsening of reciliation at only one time point post
operatively, day 84,but felt that the difference was so small, approximately l0%o, as
not to be clinically significant. Mclntosh et al. did not observe this difference when
they utilised an identical experimental protocol with hyaluronic acid-based packs in a
healthy sheep modell117]. Based on these studies, we conclude that an interaction
between the IGF-1 and the bioactive factors associated with an eosinophilic
inflammatory state, was responsible for the deleterious effects on reciliation. IGF-1
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has been noted to interact with vascular smooth muscle cells and endothelial cells
during inflammatory states and augments the pro-inflammatory activities in these
cells that are controlled by tumour necrosis factor 1 alpha (TNF1-o)tzl2l. In the
inflammatory state associated with pulmonary f,rbrosis, IGF-1 has been implicated in
promotion of fibroblast proliferation, and in acting on TNF-cr to encourage fibrosis
and granuloma formation[203]. We have previously noted and discussed the
significantly worsened and slower healing in this sheep model of chronic sinusitis as
compared to a healthy model, most likely due to the inflammatory milieu of
cytokines, growth factors, etc, which may promote healing by fibrosis and scarring,
rather than a regeneration of the normal mucosa, as well as degradative enzymes
which may denature the IGF-1.
An important areato consider, when examining the effects of IGF-I, is the concept of
cellular differentiation and ciliogenesis. Differentiation is the process where poorly
differentiated intermediate cells transform into ciliated epithelium, and ciliogenesis is
the process where cilia develop. Mitogenesis, however, describes an increase in the
number of cells, which do not necessarily pass down the path of differentiationl l6'
2131. gtr" reason that IGF-1 may not have had a beneficial effect on reciliation is that
its actions may encourage cell growth rather than cell differentiation. IGF-I has been
shown to have a role in mitogenesis in olfactory epithelium and nasal epith.li*tt[214].
In work carried out in cultured rcttracheal cells, the withdrawal of mitogenic growth
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factors such as EGF (epidermal growth factor) resulted in cell differentiatiott[167],
and the authors concluded that high levels of mitogenic growth factors may act to
prevent cell differentiation. In sheep tracheal epithelium, EGF application resulted in
the growth of basal and undifferentiated cells, with a loss of ciliated cells and goblet
."1.[215J. In a murine model, IGF-1 was shown to increase bowel length and mass,
with an overall increase in cell numbers, but was believed to encourage mitogenesis,
in comparison to growth hormone, which promoted cel| differentiationl114]. While
none of this work has defined with certainty the exact role of IGF- 1 in mitogenesis
and cell differentiation, there is little evidence that IGF-1 promotes cell
differentiation and ciliogenesis. Thus, although IGF-1 demonstrated promising results
in a wound scratch mode (Unpublished Data), that work did not specifically examine
reciliation, and conclusions car¡rot be drawn regarding reciliation.
Measurement of CBF was performed as a functional assessment of the regenerating
ciliated epithelium. There has been no previous work documenting the effect of IGF-
1 on CBF, but other cytokines such as interleukin 1p, tumour necrosis factor o have
been shown to cause an increase in CBF in human nasal epithelial cells[216].
The CBFs at each time point were recorded, and then a relative CBF value was also
calculated using the day 0 baseline values. At day 112 post operatively, the control
sides showed signif,rcantly higher CBF than the sides treated with the Merogel/IGF-l
packing, (p<0.05). Although some points of separation were noted at other time
points, these were not statistically significant. When the relative CBF values were
compared, there appeared to be a difference at day 84 in favour of the sides treated
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with the Merogel/IGF-l but this was not statistically significant. The CBF values of
the sides treated with the Merogel/IGF-1 were compared with those treated with
Merogel alone, to separate the effects that the two materials may be having on CBF.
At all time points after day 28,the CBF values of the sides treated with Merogel
alone were consistently higher than those treated with Merogel/IGF-l. Despite this
obvious trend, none of the differences were statistically significant.
One concern when incorporating bioactive agents into packing materials is the
activity of these agents beyond the target region. In previous work done in the healthy
sheep model, no systemic or extended local effect was noted in the control samples
(Unpublished Data). 'When a comparison was made between the control sides in the
sheep treated with hyaluronic acid/IGF-l packs and the control sides from the group
of sheep treated with hyaluronic acid-based packs, at day 56 post operatively there
was a significant difference between the two groups with the IGF-I controls showing
67.77% reciliation versus 79.07% reciliation in the hyaluronic acid control group
(p<0.01). This result, though perhaps not clinically significant in terms of reciliation,
was suggestive of a possible systemic or extended local effect of the IGF-I in the
packs. There appeared to be no systemic or extended local effects of the IGF-I with
regards to reepithelialisation or relative epithelial height. One could conclucle that in
the presence of inflammation and its associated cytokines and other bioactive agents,
the local absorption and spread of the IGF-1 maybe different, possibly due to
expression of IGF-1 binding proteins
In rat models, nasally applied IGF-I has been shown to influence olfactory
neurogenesisl217], and also to blpass the blood brain barrier and deliver IGF-1 to
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cerebral lissuss[218]. The inference from this is that the intranasal IGF-1, which we
administer via the hyaluronic acid-based packs, may enter the brain, bypassing the
usual protection of the blood brain barrier. Further work would have to be carried out
in the sheep model, and then possibly in human trials to confirm this, and then to
investigate the possible effects of this.
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Conclusions
The use of a hyaluronic acid-based pack impregnated with IGF-I does not confer any
benehcial effects on mucosal healing after ESS in a sheep model of chronic sinusitis,
when assessed by reepithelialisation or relative epithelial height. The use of these
packs resulted in significantly worse reciliation of the healing mucosa at both days 56
and ll2 post operatively. The IGF-I impregnated packing also had a deleterious
effect on CBF, with significantly worse CBF compared to controls at day lI2.There
may also be an extended local or systemic effect of the IGF-1, evident by
significantly \¡/orse reciliation in control samples when compared to control samples
from a previous study where the packing used was the plain hyaluronic acid based
packs. With regards to CBF, again there appeared to be a harmful systemic effect of
the IGF-1, with controls demonstrating significantly lower CBF at day 84 compared
to the controls for the sheep treated with the hyaluronic acid packs alone. The
deleterious effects on reciliation and ciliary function may be due to an interaction
between the IGF-I and the bioactive substances associated with an inflammatory
state, and also due to the IGF-I acting to promote cell growth rather than cell
differentiation and the associated ciliogenesis.
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Conclusions
The work discussed in this thesis has demonstrated a number of important points. The
presence of chronic eosinophil driven sinusitis, induced by the infestation with the
oestrous ovus nasal parasite in the sheep model, results in impaired and slower
mucosal healing after ESS when compared to healtþ sheep. In the presence of this
inflammation, the use of a hyaluronic acid based nasal packing, Merogel@, confers
no benehcial effects on mucosal healing when assessed by mucosal
reepithelialisation, relative epithelial height, reciliation, measurement of CBF or
prevention of adhesion formation. When IGF- 1 is impregnated into this packing
material, again there are no beneficial effects on mucosal healing when assessed by
the same parameters. There is however, a significant slowing of mucosal reciliation
when the IGF-I is used, and a suggestion that the IGF-I has an extended local, or
systemic effect.
While this sheep model of chronic sinusitis is analogous to the disease state in human
patients, it differs in that when patients are treated for their sinus disease, the source
of their inflammation is usually removed and treated at the time of surgery, whereas
in this model, the inflammatory state was allowed to continue on during the healing
process. This has demonstrated the importance of removal of all inflammatory tissue
and debris at the time of surgical management, as any material left behind which may
prolong the inflammatory process will have implications on the healing process.
Certainly, it appears that the ongoing inflammatory state is responsible for the lack of
efficacy of the hyaluronic acid packing and the IGF-I in this model.
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Further work with this model should involve the treatment of the nasal parasite at the
time of surgery to halt the inflammatory process, which would then allow the tissue
to heal in a fashion analogous to human patients, and allow the evaluation of the
therapeutic interventions such as hyaluronic acid based pacing and IGF-I in a
situation similar to that in which they would be used in human patients. This sheep
model of chronic sinusitis will prove useful for this, and for the evaluation other
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